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1. Introduction 
The centrosome is the main microtubule organizing center (MTOC) and plays an important 
role in mitotic spindle orientation and genome stability (Bornens, 2012). It nucleates, anchors, 
and organizes microtubules. In animal cells it comprises a pair of centrioles and a surrounding 
pericentriolar matrix (PCM) (Fig. 1). The PCM is a key structure of the centrosome and is 
responsible for microtubule nucleation and anchoring. The major components of the PMC are 
large coiled coil proteins like pericentrin and proteins of the AKAP450 family that provide 
docking sites for γ-tubulin ring complexes and regulatory molecules. They allow the 
centrosome to function as MTOC and to carry out its regulatory functions during cell cycle 
transitions, cellular responses to stress, and organization of signal transduction pathways 
(Keryer et al., 2003; Doxsey et al., 2005).  
 
Figure 1. An artistic view of the MTOC with its star pattern of microtubules radiating 
from the cylindrical centrioles to all parts of the cell. Source: Studiodaily, New York. 
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1.1 Centrosome and centriole biology 
The centrosome was considered as the organ coordinating karyokinesis and cytokinesis. The 
absence of the centrosome in an unfertilized egg was seen as an efficient way to avoid 
parthenogenetic development (Bornens, 2012). The centrosome morphology varies largely in 
protozoa, algae, and fungi. In Dictyostelium discoideum it is a nucleus associated body 
consisting of a box-shaped core surrounded by the corona, an amorphous matrix functionally 
equivalent to the PCM (Ueda et al., 1999). The centrosome of animal cells is a cytoplasmic 
organelle formed around a core structure made of two microtubule-based cylinders of defined 
length and diameter, the centrioles, with a highly conserved nine fold radial symmetry 
(Bobinnec et al., 1998). The centriole pair comprises of a mature mother centriole and a 
young daughter centriole. It displays structural and functional asymmetry due to the 
generational difference between each member of the pair: The old, fully mature mother 
centriole is distinguished by two sets of nine appendages at its distal end whereas the young, 
immature, daughter centriole, assembled during the previous cell cycle, is about 80% the 
length of the mother centriole (Piel et al., 2000). Both centrioles are connected together by a 
linker comprising of various centrosomal proteins, the major ones being C-Nap1 and 
Rootletin. More recently, CDK5RAP2 was identified as a putative linker component which 
surrounds the centrioles (Graser et al., 2007). 
Studies on early C. elegans embryos with genetic and RNA interference based approaches 
gave major insight into molecular mechanisms of centriole biogenesis (Leidel et al., 2005; 
Leidel and Gönczy, 2003; O’Connell et al., 2001). These studies revealed an ordered 
assembly pathway that involves the products of just five essential genes, termed zyg-1 
(Zygote defective-1), spd-2 (Spindle defective-2), and three Spindle assembly genes sas-4, 
sas-5, and sas-6 (Delattre et al., 2006; Pelletier et al., 2006). SAS-4, SAS-5, SAS-6, and SPD-
2 are coiled-coil proteins, whereas ZYG-1 is a protein kinase. Shortly after fertilization of the 
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egg, SPD-2 is recruited to the paternal centrioles, which then allows the centriolar recruitment 
of ZYG-1. Next, a complex comprising SAS-5 and SAS-6 is recruited, which leads to the 
formation of a “central tube” that is closely associated with the original centriole. The central 
tube encompasses the highly conserved nine fold radial symmetry of the centriole/basal body 
(Kitagawa et al., 2011). In most species, the centriole is organized around a cartwheel that 
comprises a central hub of 25 nm in diameter from which nine spokes radiate outward and 
connect to nine microtubule blades (Strnad and Gönczy, 2008). The major molecular architect 
of the central hub of the cartwheel is found to be SAS-6, the oligomerisation properties of 
which help in self-assembling to form 9 radiating spokes (Kitagawa et al., 2011). Finally, 
SAS-4 facilitates the assembly of microtubules onto the periphery of this tube, resulting in the 
formation of a procentriole (Pelletier et al., 2006) (Fig. 2).  
 
Figure 2. Centriole duplication in C. elegans embryos. SPD-2 recruits the protein kinase 
ZYG-1 to mother centrioles, which then recruits a complex of SAS-6 and SAS-5. This 
promotes the formation of a central tube (red) at right angles to the mother centriole. SAS-6 
and SAS-5 then recruit SAS-4, which allows the centriolar microtubules (green) to associate 
with the central tube, thus forming the procentriole. The protein γ-tubulin is also required to 
convert the structure in to a procentriole. The proteins highlighted in red all have functional 
orthologs implicated in centriole duplication in other species (adapted from (Nigg and Raff, 
2009). 
Importantly, the significance of these findings is not limited to C. elegans. Although an 
ortholog of SAS-5 awaits definitive identification, SPD-2, SAS-4, and SAS-6 clearly have 
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orthologs in human cells termed Cep192 (Andersen et al., 2003), CPAP/HsSAS-4 (Hung et 
al., 2000), and HsSAS-6 (Leidel et al., 2005), respectively. Curiously, ZYG-1 does not have 
obvious structural orthologs outside of nematodes, but the available evidence suggests that 
PLK4 plays a functionally analogous role in human cells (Bettencourt-Dias et al., 2011; 
Habedanck et al., 2005). 
In the last decade, the molecular composition of the isolated centrosome in the human and fly 
has revealed a number of proteins conserved across eukaryotes (Azimzadeh and Marshall, 
2010; Carvalho-Santos et al., 2011). For the protein inventory of the Dicytostelium 
centrosome more than 70 new candidates have been identified (Reinders et al., 2006). In 
higher vertebrates, sequence database searches resulted in the identification of more than 
2,000 peptides representing more than 500 proteins in the peak centrosome fraction (Andersen 
et al., 2003). Functional genomics in nematodes and flies has identified a small set of 
conserved proteins required for the initiation of centriole/basal body assembly and for 
centrosome reproduction.  
1.2 Autosomal recessive primary microcephaly 
The cellular regulation by centrosomes has been well studied. Increasing evidence indicates 
that this structure may be well designed for the organization of multiprotein scaffolds that can 
anchor a diversity of activities ranging from protein complexes involved in microtubule 
nucleation to multicomponent pathways in cellular regulation (Doxsey et al., 2005). The 
centrosome is an indispensable component of the cell-cycle machinery of eukaryotic cells, 
and perturbation of core centrosomal or centrosome-associated proteins is linked to cell-cycle 
misregulation and cancer (Badano et al., 2005). The structural complexity of the centrosome 
is reflected in its biochemical composition with a large number of proteins localized either in 
the centrioles or in the centrosomal matrix  among which several are disease gene products 
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(Nigg and Raff, 2009; Kobayashi and Dynlacht, 2011). Aberrations in several centrosomal 
proteins are also reported in primary microcephaly (Table 1). 
Locus name    Protein name    Localization 
MCPH1    Microcephalin    Centrosome 
MCPH2    WDR62     Centrosome 
MCPH3    CDK5RAP2/Cep215    Centrosome 
MCPH4    CASC5     Kinetochore 
MCPH5    ASPM     Centrosome 
MCPH6    CPAP/CENPJ    Centrosome 
MCPH7    STIL      Centrosome 
MCPH8    CEP135     Centrosome 
MCPH9    CEP152     Centrosome 
MCPH10    ZNF335     Nucleus 
MCPH11   PHC1     Nucleus 
MCPH12    CDK6      Centrosome 
SCKL6    CEP63     Centrosome 
Table 1. Genes implicated in MCPH (adapted from Nigg et al., 2014).  
Autosomal recessive primary microcephaly, often shortened to MCPH which stands for 
"microcephaly primary hereditary", is a condition in which infants are born with a very small 
head and a small brain (Fig. 3). The term "microcephaly" comes from the Greek word for 
"small head". The MCPH-associated genes described to date have been implicated in cell 
division and cell cycle regulation and many of them have been localized to the centrosome 
(Kaindl, 2014).  
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Figure 3. MRI images of a patient at 15 months (on the left) compared to a normal age and 
gender matched child (on the right) demonstrating cranio-facial disproportion characteristic of 
microcephaly (adapted from Pagnamenta et al., 2012). 
MCPH is a rare neurodevelopmental disorder that results in severe microcephaly at birth with 
pronounced reduction in brain volume, particularly of the neocortex, simplified cortical 
gyration and intellectual disability (Issa et al., 2013b). Mutations in MCPH genes reduce the 
population of neurons in each of the six layers of the cerebral cortex during development, but 
there is little or no overt structural abnormalities other than reduced thickness of the cerebral 
cortex (Megraw et al., 2011). Patients with mutations in MCPH loci show moderate to severe 
microcephaly. Some of the notable phenotypes of microcephaly patients are decrease in size 
of head and brain volume (Bond et al., 2003, 2005), sensorineural hearing loss (Pagnamenta 
et al., 2012), short stature, seizures (Darvish et al., 2010) and mental retardation (Neitzel et 
al., 2002), but no motor deficit.  
Mutations in the ASPM (Abnormal spindle-like microcephaly associated) gene is the most 
frequent cause of MCPH. Analysis of mouse and zebrafish mutants for Aspm demonstrates 
that Aspm is crucial for maintaining a cleavage plane orientation that allows symmetric, 
proliferative divisions of neuro-epithelial cells during brain development. Failure to do so 
leads to microcephaly disease condition (Pulvers et al., 2010; Fish et al., 2006; Novorol et al., 
2013). Cdk5rap2
an/an
 mutant mice (Hertwig's anemia mouse, in which an inversion of the exon 
4 of Cdk5rap2 gene leading to the deletion of a large part of the gamma-tubulin ring complex 
binding domain) showed a dramatic reduction in brain size and thin superficial cerebral cortex 
layers and rarely survived beyond 1 week of age. The Cdk5rap2 mutants exhibited a 
significant decrease in the ratio of brain to body weight as compared with controls (Lizarraga 
et al., 2010). It has been reported that CDK5RAP2 shares homology at the amino terminus 
with several eukaryotic proteins, including Schizosaccharomyces pombe Mto1p (also known 
as Mbo1p and Mod20p) and Pcp1p, and Drosophila melanogaster centrosomin (Cnn), which 
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have been shown to function in the recruitment of γ-tubulin to MTOCs through interacting 
with γTuRCs (Fong et al., 2008). Mutation in the CDK5RAP2 homolog in Drosophila, Cnn, 
led to abnormalities in asymmetric division in the larval brain (Wakefield et al., 2001). 
Recently, cerebral organoid cultures with a mutation in Cdk5rap2 led to the observation of 
smaller embryoid bodies, which when subjected to neural induction failed to develop further 
(Lancaster et al., 2013). The centrosomal localization of the MCPH-associated proteins, 
particularly during the cell cycle, underlines the role of the centrosome in the etiology of this 
disease (Megraw et al., 2011). 
1.3 Cyclin Dependent Kinase 5 regulatory subunit-associated protein 2 (CDK5RAP2) 
The human CDK5RAP2 gene is located on chromosome 9, has 38 exons spanning a region of 
191 kb, and the deduced open reading frame encompasses 6130 bp encoding 1893 amino 
acids. So far four isoforms produced by alternative splicing have been reported: Isoform 1, the 
full-length form (UniProt ID: Q96SN8-1); Isoform 2, missing residues 702–733 at exon 19 
(UniProt ID: Q96SN8-2); Isoform 3, missing residues 1009–1049 at exon 23 (UniProt ID: 
Q96SN8-3); Isoform 4, missing residues 1576–1654 at exon 32 (UniProt ID: Q96SN8-4) 
(Kraemer et al., 2011). To date, four different mutations have been identified in CDK5RAP2: 
a nonsense mutation in exon 4 (c.246T > A, p.Y82X), an A to G transition in intron 26 
(c.4005-15A > G, p. R1334SfsX5) introducing a new splice acceptor site, a frame shift and a 
premature stop codon, a nonsense mutation in exon 8 (c.700G > T, p.E234X) and a nonsense 
mutation, c.4441C > T (p.Arg1481) introducing a premature stop codon (Bond et al., 2005; 
Hassan et al., 2007; Pagnamenta et al., 2012b; Issa et al., 2013b). 
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Figure 3. Schematic representation of the domain structure of CDK5RAP2. γTuRC: 
Gamma-Tubulin ring complex, SMC: Structural maintenance of chromosomes, EB1: End 
binding 1, CDK5R1: Cyclin dependent kinase 5 activator 1, CM2: Cnn Motif 2 (picture 
modified from Issa et al. 2013b). 
The human CDK5RAP2 protein (NP_060719.4) contains a predicted N-terminal interaction 
site for the gamma tubulin ring complex (γTuRC) (Fong et al., 2008), two structural 
maintenance of chromosome (SMC) domains, a Ser-rich motif for interaction with plus-end 
tubulin binding protein EB1 (Fong et al., 2009), an interaction site for Cyclin dependent 
kinase 5 activator 1 (CDK5R1) (Wang et al., 2000) and Pericentrin (Buchman et al., 2010), 
and a CM2 (Cnn Motif 2) domain which is responsible for sequestering it to the centrosome 
and the Golgi apparatus which has a pericentrosomal location. The CM2-like sequence of 
CDK5RAP2 exhibits Ca
2+
-independent calmodulin binding activity (Wang et al., 2010).  
1.3.1 Physiological functions of CDK5RAP2 
CDK5RAP2 is a pericentriolar structural component that functions in γTuRC attachment and 
therefore in the microtubule organizing function of the centrosome (Fong et al., 2008). The 
EB1 domain of CDK5RAP2 interacts with the growing microtubule tips and hence regulates 
microtubule dynamics (Fong et al., 2009). Furthermore, CDK5RAP2 also regulates mitotic 
spindle positioning, asymmetric centrosome inheritance, DNA damage signaling (Barr et al., 
2010) and also has spindle checkpoint function (Zhang et al., 2009b). In addition, 
CDK5RAP2 is reported to restrict centriole replication by maintaining centriole engagement 
and cohesion (Barrera et al., 2010). Besides, CDK5RAP2 regulates chromosome segregation 
in neuronal progenitors (Lizarraga et al., 2010). In conjunction with further in vitro studies, 
CDK5RAP2 function specifically contributes to centrosome asymmetry (Conduit and Raff, 
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2010), centriole replication control and primary cilium formation (Barrera et al., 2010), 
kinetochore attachment to spindles and checkpoint control (Zhang et al., 2009b), binding to 
the dynactin complex (Lee and Rhee, 2010), cell-cycle regulation and cell-cycle exit 
(Buchman et al., 2010), microtubule plus-end dynamics (Fong et al., 2009), mitotic spindle 
formation, function and orientation (Lizarraga et al., 2010). 
From the human phenotype and animal models, it has become clear that CDK5RAP2 has an 
influence on brain size regulation during fetal development (Issa et al., 2013a). Nonsense and 
splice mutations in CDK5RAP2 result in truncated, non-functional proteins in microcephaly 
patients (Issa et al., 2013b). Some of the notable patient phenotypes resulting from 
CDK5RAP2 mutations are sensorineural hearing loss, intellectual disability and a reduced 
occipital frontal head circumference (Pagnamenta et al., 2012; Issa et al., 2013; Tan et al., 
2014). Whether mutations in CDK5RAP2 and the decrease in neuronal cell density are 
associated with altered signal transduction pathways is not known.  
1.4 Hippo signaling pathway 
The Hippo signaling pathway is a tumor-suppressive pathway and is inactive at low cell 
density (Mori et al., 2014). It primarily affects the number of cells produced and has only 
minor effects on tissue patterning (Harvey et al., 2003) and is known as a key regulator of 
organ growth and tissue size in Drosophila and mouse (Udan et al., 2003; Lee et al., 2010; Lu 
et al., 2010; Halder and Johnson, 2011). At the center of the Hippo pathway is a core kinase 
cassette that consists of a pair of related serine/threonine kinases, mammalian STE20-like 
protein kinase 1 (MST1 and MST2) which are homologues of D. melanogaster Hippo (HPO), 
and large tumour suppressor 1 (LATS1) and LATS2 together with the adaptor proteins 
Salvador homologue 1 (SAV1) and MOB kinase activator 1A (MOB1A) and MOB1B 
(Harvey et al., 2003; Udan et al., 2003; Pantalacci et al., 2003; Tapon et al., 2002; Justice et 
al., 1995; Kango-Singh, 2002). These proteins limit tissue growth by facilitating LATS1- and 
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LATS2-dependent phosphorylation of the homologous oncoproteins Yes-associated protein 
(YAP) and Transcriptional co-activator with PDZ-binding motif (TAZ) (Huang et al., 2005) 
(Fig. 4). 
 
Figure 4. Schematic of the Hippo pathway in mammals. Cells (outlined in grey, nuclei in 
green) are shown with adherens junctions (AJ). Hippo pathway components in vertebrates are 
shown in various colors, with pointed and blunt arrowheads indicating activating and 
inhibitory interactions, respectively. Continuous lines indicate direct interactions, whereas 
dashed lines indicate unknown mechanisms (adapted from Halder and Johnson, 2011). 
Phosphorylation of YAP and TAZ represses their activity by creating binding sites for the 
protein 14-3-3. The name 14-3-3 was initially coined by Moore and Perez in 1967 with regard 
to the particular elution and migration pattern of these proteins on DEAE-cellulose 
chromatography and starch-gel electrophoresis. The 14-3-3 proteins eluted in the 14th fraction 
of bovine brain homogenate and were found on positions 3.3 of subsequent electrophoresis 
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(Moore and Perez., 1967). The interaction of YAP/TAZ with 14-3-3 causes them to 
accumulate in the cytoplasm and that also stimulates their ubiquitin-mediated proteolysis 
(Zhao et al., 2007; Dong et al., 2007). YAP and TAZ and their D. melanogaster counterpart 
Yorkie (YKI) do not contain intrinsic DNA-binding domains but instead bind to the 
promoters of target genes through interaction with transcription factors. They promote tissue 
growth and cell viability by regulating the activity of different families of transcription 
factors, including Transcriptional enhancer factor domain (TEAD) and Similar to mothers 
against decapentaplegic (SMAD) family members (Hong et al., 2005). TEADs seem to be key 
mediators of growth and the tumorigenic potential of YAP, TAZ and YKI, but the genetic 
program that these factors regulate to drive tissue growth is not well defined (Hong et al., 
2005).  
The Hippo pathway is conserved throughout evolution and key kinase components have also 
been detected in D. discoideum (Rohlfs et al., 2007; Artemenko et al., 2012). In Drosophila, 
loss - of - function mutant clones for any of the genes Warts, Salvador, Hippo and Mats lead 
to a strong tissue overgrowth phenotype characterized by increased proliferation and 
diminished cell death.  
1.4.1 Hippo signaling in mammalian organ size determination 
In mammals, the first studies that connected Hippo signaling to organ size control employed a 
Yap overexpression strategy that mimicked pathway inactivation and showed that the 
induction of Yap expression in the adult mouse liver led to a dramatic three- to fourfold 
increase in liver mass as a result of increased cell numbers (Dong et al., 2007). Remarkably, 
when Yap overexpression was terminated, the liver rapidly reverted to its normal size, 
suggesting that intrinsic size control mechanisms were then activated, presumably to reduce 
cell numbers through an apoptotic process (Dong et al., 2007). These studies infer that Hippo 
signaling is crucial for regulating the size of the mammalian liver, and that it acts through a 
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mechanism that integrates global organ size control signals with the regulation of Yap. 
However, although the effect of Yap overexpression on liver size is dramatic, whether Hippo 
signaling is required to maintain liver size was not addressed by these studies. These findings 
show that Hippo signaling functions in regulating the size of the liver, despite this it appears 
that Hippo signaling, at least the one mediated by the Mst1 and Mst2 kinases, does not 
regulate the size or growth of other mammalian tissues to the same degree (Song et al., 2010).  
1.4.2 Hippo signaling at the centrosome 
The regulation of centrosomal biology by the Hippo components is presently a topic of 
intense research. The components of Hippo signaling pathway regulate the association of 
Nima-related Kinase 2 (NEK2) with the centrosome (Mardin et al., 2010). Nek2 is the direct 
substrate for phosphorylating the centrosomal linker proteins C-Nap1 (centrosomal Nek2-
associated protein 1) and Rootletin which causes their dissociation from centrosomes and 
enables centrosome separation (Fry et al., 1998; Mayor et al., 2002; Bahe et al., 2005). It has 
also been demonstrated that Mst2 phosphorylates Nek2A, thereby recruiting Nek2A to 
centrosomes and promoting phosphorylation and displacement of centrosomal linker proteins. 
Additionally, it was shown that the hSav1–Mst1/Mst2–Nek2A pathway cooperates with 
forces provided by the kinesin motor Eg5 to allow centrosome separation and bipolar spindle 
formation (Mardin et al., 2010). Strikingly, certain Hippo pathway components, including the 
Lats and Mst1/Mst2 kinases and the scaffolding protein hSav1, localize to centrosomes (Guo 
et al., 2007). In addition, Mst1 was reported to control centrosome duplication (Hergovich et 
al., 2009). Another important member of the hippo pathway, hMOB1, also plays a role in 
centrosome duplication (Hergovich et al., 2009) and localises to the centrosomes (Wilmeth et 
al., 2010). LATS2 was also observed at the centrosome throughout cell cycle and was 
associated with Ajuba during mitosis which regulates spindle organization through 
recruitment of γ-tubulin to centrosomes (Abe et al., 2006).  
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1.5 Dictyostelium discoideum as a model organism 
D. discoideum amoebae belong to the monophyletic group of mycetozoans that stands close to 
animals and fungi. Dictyostelium is a simple eukaryote that lives in the soil and feeds on 
bacteria by phagocytosis. The life cycle of Dictyostelium consists of growth and 
developmental phases. The individual cells divide by binary fission as long as food is present, 
however, when bacteria are exhausted, starvation triggers a process of chemotaxis driven by 
cyclic-AMP (cAMP) (Willard and Devreotes, 2006; Janetopoulos and Firtel, 2008). The 
cAMP signaling stimulates the single cell amoebae to aggregate to form multicellular 
structures leading to the development of fruiting body consisting of a stalk and a spore head 
filled with spores, and the release of the spores (Fig. 5).  
 
 
Figure 5. D. discoideum  life cycle. Representative pictures of vegetative and developmental 
stages are shown (picture adapted from Calvo-Garrido et al., 2010). 
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In the wild, Dictyostelium amoeba feed on soil bacteria by phagocytosis but most laboratory 
strains are also able to grow in liquid axenic media by macropinocytosis. It is important to 
point out that cells are haploid throughout these vegetative and developmental cycles and this 
facilitates the generation of knockout strains (Calvo-Garrido et al., 2010). Despite its 
simplicity, Dictyostelium shows striking similarities with higher eukaryotes in many 
biological aspects including chemotaxis (Van Haastert and Veltman, 2007), developmental 
signaling pathways (Strmecki et al., 2005), the response to bacterial infections (Steinert and 
Heuner, 2005), the response to therapeutic drugs (Alexander et al., 2006) and programmed 
cell death including autophagic cell death (Giusti et al., 2009). Dictyostelium is an alternative 
model organism for centrosome research in addition to yeast and animal cells. With the 
elucidation of morphological changes and dynamics of centrosome duplication, the 
establishment of a centrosome isolation protocol, and the identification of many centrosomal 
components, there is a solid basis for understanding the biogenesis and function of this 
organelle (Gräf et al., 2004).  
The Dictyostelium genome has been fully sequenced (Eichinger et al., 2005) and well-
annotated data are publicly available (http://dictybase.org/). Moreover, it is amenable to a 
wide range of molecular genetic techniques including the generation of mutants by 
homologous recombination and random genetic screens, that have facilitated the comparative 
genomics to identify relevant genes conserved in the human genome (Torija et al., 2006). 
Thus, NIH has cited Dictyostelium discoideum as a non-mammalian model organism for 
biomedical research (http://www.nih.gov/science/models/). 
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1.6  Aim of this study. 
The aim of this study is to characterise the D.discoideum CEP161 protein which we initially 
identified as a binding partner of CP250, a novel centrosomal protein with important roles in 
growth and development (Blau-Wasser et al., 2009). CEP161 was characterised based on 
following features: 
1. Homology to proteins from other species 
2. Subcellular localization. 
3. Analysis of CEP161 in various physiological functions of the cell ranging from size, 
nuclear number, centrosome-nuclear distance and ratio, growth, development, motility 
to multicellular migration. 
4. Its ability to interact with Dd Hippo related kinase-severin kinase. 
The final part of the study was focused on the interaction of human CDK5RAP2 with MST1 
and TAZ and hence to characterize the role of CDK5RAP2 in the Hippo signaling pathway. 
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2. Results 
2.1 Identification and characterization of the pericentriolar matrix protein CEP161, the 
D. discoideum ortholog of CDK5RAP2 
2.1.1 Identification of CEP161 as an interacting partner of CP250 
We identified CEP161 as interaction partner of the centrosomal protein CP250 in 
immunoprecipitation experiments using GFP-CP250, a component of the pericentriolar 
matrix, followed by mass spectrometry analysis (Blau-Wasser et al., 2009). We then 
expressed different parts of CEP161 as GST fusion proteins to identify its binding site for 
CP250 and found that we could pull down GFP-CP250 from whole cell lysates with amino 
terminal sequences 1-763 (data not shown). A direct interaction of the proteins was shown by 
yeast-two-hybrid experiments in which the N-terminal sequences of CEP161 (residues 1-763) 
interacted with residues 1-1148 of CP250 (Fig. 6). 
 
Figure 6. N-terminal part of CEP161 interacts with CP250. Yeast-2-hybrid analysis 
showing the direct interaction of pAS-CP250 (residues 1-1148) with pACT-CEP161 (residues 
1-763), whereas pACT-CEP161 (residues 763-1114) did not show any interaction. The Y2H 
analysis for pAS-CP250 (residues 1-1148) with empty vector pACT was used as a negative 
control. 
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2.1.2 CEP161 domain and sequence alignment  
The gene encoding CEP161 (DDB_G0282851) is located on chromosome 3 and has 2 exons. 
The open reading frame comprises 4146 base pairs and codes for a protein of 1381 aa with a 
molecular mass of 161,600. The protein was named CEP161 based on its molecular mass and 
location (see below). The BLAST prediction program revealed an N-terminal -Tubulin ring 
complex (-TuRc) domain (residues 99-174); the SMART prediction tool indicated the 
presence of four coiled-coil domains in the protein (Fig. 7A). The -TuRc domain 
(pfam07989) is present in several microtubule associated proteins which also include 
CDK5RAP2. The highest conservation is in a consensus ten amino acid motif as shown for 
the human, Drosophila and D. discoideum protein (Fig. 7B). 
A 
 
B 
 
Figure 7. CEP161 domain and sequence alignment. A. CEP161 domain structure. B. 
CDK5RAP2 -TuRc domain sequence alignment and the protein accession numbers for the 
Human (Hs) (NP_060719), Drosophila melanogaster (Dm) (NP_725298.1) and D. 
discoideum protein (Dd) (DDB_G0282851). The numbers indicate the amino acid position of 
the -TuRc domain in the respective proteins. Colour code: Red background shows the 
residues which are strictly conserved in the column, yellow background shows the residues 
which are conserved within a group but not conserved from one group to the other. 
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2.1.3 CEP161 is a centrosomal protein. 
To determine the subcellular localisation of CEP161, we generated monoclonal antibodies 
against a recombinant polypeptide (CEP161-D1, residues 1-763). mAb K83-632-4 showed in 
immunofluorescence studies a bright punctate staining near the nucleus suggestive of the 
centrosome (Fig. 8A). The centrosomal localization was confirmed by labeling GFP-CP250 
knock-in cells where the antibody staining coincided with the GFP positive centrosome. GFP 
tagged CEP161 also was present in a single dot near the nucleus and was recognized by mAb 
K83-632-4 (Fig. 8B).  
A 
 
B 
 
Figure 8: CEP161 as a novel centrosomal protein in D. discoideum. A. Localisation of 
CEP161 to the centrosomes in AX2 cells. The CEP161 genomic DNA sequence was cloned 
into pBsrN2 to produce CEP161 proteins with GFP located at the N-terminus. B. Cellular 
localisation of CEP161 to the centrosome in GFP-CP250 cells and in GFP-CEP161 cells. 
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CP250 was expressed as GFP-fusion rotein, CEP161 was detected with mAb K83-632-4, 
nuclei were stained with DAPI (Scale bar, 10 µm). 
 
The centrosome and the Golgi apparatus co-localize in the vicinity of the nucleus. When we 
stained GFP-CEP161 cells with mAb190-340-8 for the Golgi marker comitin, we found 
CEP161 in the center of the Golgi apparatus (Fig. 9). 
 
Figure 9: CEP161 localises to the Golgi-complex. CEP161 is a novel centrosomal protein in 
D. discoideum which also localises with the Golgi-complex as revealed by comitin staining 
with mAb 190-340-8, nuclei were stained with DAPI (Scale bar, 10 µm). 
 
2.1.4 CEP161 constructs and truncated proteins 
To identify the region of CEP161 that mediates the centrosome association of CEP161, we 
generated shortened proteins (GFP-CEP161-D1: designated D1, residues 1-1114; GFP-
CEP161-D2: designated D2, residues 1-763; and GFP-CEP161-D3: designated D3, residues 
763-1114) (Fig. 10A). Expression and molecular weights of the GFP tagged proteins were 
analysed by SDS-PAGE (Fig. 10B).  
A 
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Figure 10. CEP161 constructs and protein expression. A. Overview of N-terminally GFP 
tagged CEP161 proteins. The position of the amino acids is given. B. Western blot for the 
GFP tagged proteins stably expressed in AX2 cells. Alpha-tubulin was used as the loading 
control. GFP fusion proteins were recognized by mAb K3-184-2, α-tubulin by YL1/2.  
 
The expression levels varied for the GFP tagged proteins. GFP-CEP161 was present in lower 
amounts than endogenous CEP161 whereas GFP-D1 levels were 1.8 fold higher than those of 
CEP161 (Fig. 11A, B).  
 
A 
 
 
 
 
 
32 
 
B 
 
Figure 11. Quantification of CEP161. A. Western blot for endogenous CEP161 and GFP 
tagged proteins detected with CEP161 polyclonal antibodies. The arrow indicates the 
endogenous CEP161. B. Quantification of western blots for endogenous CEP161 and GFP 
tagged proteins. 
 
2.1.5 Localisation of CEP161 truncated proteins 
In immunofluorescence analysis the D1 and D2 proteins behaved like a centrosomal protein 
and appeared as a single dot near the nucleus. In contrast, the D3 protein was present 
throughout the nucleus although the prediction programs did not reveal nuclear localization 
signals or any DNA binding domain. We conclude that amino acids 1-763 are sufficient for 
localization of CEP161 to the centrosome (Fig. 12).  
 
Figure 12. Subcellular localisation of GFP tagged proteins. For GFP-CEP161-D3 the 
centrosome was detected with mAb K68-332-3.Nuclei were stained with DAPI (Scale bar, 5 
µm). 
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Based on its overall domain structure, the presence of the conserved -TuRc and the 
localization at the centrosome we presume that CEP161 is the D. discoideum ortholog of 
CDK5RAP2. 
 
2.2 CEP161 mutant cells are viable, but impaired in growth and development 
2.2.1 CEP161 regulates nuclear number and centrosome positioning 
Isolation of a knockout mutant has not been successful. Therefore we overexpressed the GFP 
tagged versions of CEP161 full length and truncated proteins in AX2 cells in order to analyse 
the role of CEP161 for cell organization, growth and development. First we determined the 
nuclei number of the cells to understand the role of CEP161 in cell division and cell cycle. 
The D1, D2 and D3 cells were mostly mononucleated with their centrosome located very 
close to the nucleus in a distance of < 500 nm. By contrast, CEP161 affected the centrosome 
nucleus distance and approximately 40% of the CEP161 cells had the centrosome far away 
from the nucleus with a distance > 900 nm (Fig. 13A, B). We also observed that the nuclei-
centrosome ratio was aberrant in a low percentage of the D1 and D2 expressors.  
A 
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Figure 13. CEP161 regulates nuclear number and centrosomal position. A. Number of 
nuclei per cell. B. Percentage of cells with nucleus-centrosome distance as indicated. A total 
of 600 cells were counted for AX2 and mutant strains for each of the experiments shown in A, 
B. 
 
2.2.2 The nuclear-centrosome ratio is altered in the mutants 
Furthermore, 0.6% of the D1 cells had two centrosomes per nucleus. For D2 cells this number 
increased to 0.74%, and in 0.24% of the cells we observed 3 and more centrosomes per 
nucleus (Fig. 14A, B). This was not observed for all other strains.  
A 
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Figure 14: CEP161 regulates centrosomal number.  A. Percentage of cells with nuclear-
centrosome ratio. A total of 600 cells were counted for AX2 and mutant strains. D. Confocal 
images for D1 and D2 cells with abnormal distribution of nucleus-centrosome ratio. Nuclei 
were stained with DAPI, centrosomes were detected with the GFP signal of the GFP tagged 
D1 and D2 proteins. Scale bar, 5 µm. 
 
2.2.3 CEP161 regulates cell size 
Ectopic expression of CEP161 led to an increase in cell size with approximately 70% of the 
cells having a diameter greater than 12 µm. Interestingly, D1 (55%), D2 (52%) and D3 (70%) 
cells showed a decrease in the size of the cells and had a diameter below 10 µm (Fig. 15).  
 
Figure 15. CEP161 regulates size. Cell size of the AX2 and CEP161 mutant strains in 
micrometers. 
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2.2.4 Role of CEP161 for growth  
To examine the role of CEP161 for growth we assessed the phenotype of AX2 and CEP161 
mutants on a bacteria lawn by measuring the increase in the diameter of the colony over time. 
Colony growth was significantly reduced for all mutants except for D3 which showed 
increased growth (Fig. 16A, B). Such a behavior could be due to reduced phagocytosis or to 
altered motility. Hence we assayed the phagocytic capability following yeast particle uptake. 
We found that fewer CEP161, D1 and D2 cells had ingested one or more yeast particles after 
15 min than AX2 cells. D3 was similar to AX2 (Fig. 16C). In suspension culture the growth 
was reduced for the CEP161 and the D3 mutants, the D1 and D2 mutants showed a faster 
growth until day 5 after which there was a sharp decrease in the growth of the cells (Fig. 
16D). 
A 
 
B 
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Figure 16: CEP161 affects growth. A. Growth on K. aerogenes. The increase of the plaque 
size was measured over days. B. Phenotype of AX2 and CEP161 mutants grown on a lawn of 
Klebsiella. The pictures were taken at day 6 after inoculation. C. Phagocytosis assay. TRITC 
labeled yeast were added to the cells. After 15 min incubation time the cells were fixed and 
the number of ingested yeast counted. D. Growth in shaking culture. The cell numbers were 
determined every 24 hours. 
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2.2.5 CEP161 affects development 
When D. discoideum cells starve, they enter a developmental cycle that ends with the 
formation of fruiting bodies. The CEP161, D1 and D2 cells plated on phosphate agar 
aggregated and formed multicellular structures, the D3 cells could only form loose aggregates 
that did not develop into fruiting bodies. There was also marked increase in the size of the 
fruiting bodies for D1 and D2 mutants, both with regard to the length of the stalks and the size 
of the fruiting bodies, whereas the CEP161 fruiting bodies were not significantly different 
from those of AX2 (Fig. 17).  
 
Figure 17. Development of wild type and mutant strains on phosphate agar plates. 
Pictures taken at 24 hours after starvation in phosphate agar plates. Scale bar 500 µm.   
 
Development was also studied on a plastic surface with cells kept in Soerensen phosphate 
buffer. Under these conditions cells can form streams and aggregate. Further development 
does not take place. We observed that stream formation occurred slightly later for CEP161, 
D1 and D2 (9 h) as compared to AX2 (8 h). For the D3 cells we noted a severe delay in the 
streaming and aggregation behavior as they formed streams only after 28 hours (Fig. 18A). 
We then analyzed the expression levels of contact site A (csA) glycoprotein when cells were 
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starved in shaken suspension. csA gene expression is developmentally regulated and starts 
during aggregation reaching a peak at the tight aggregate stage. The protein is a cell adhesion 
molecule which enables cells to form EDTA stable cell-cell contacts during aggregation (Faix 
et al., 1990). In the experiment shown csA was detected in D1 at t6 and the amounts strongly 
increased at t8 and t10. In AX2, CEP161and D2 csA was present at t8 and the level increased 
at t10. In D3 csA was also seen at t8 and t10, however, the amounts were lower. At the t24 
time point, when tight aggregates had formed in all strains, the csA signal was identical in all 
strains (Fig. 18B). We conclude that ectopic expression of CEP161 does not significantly alter 
development, whereas D1 and D2 lead to premature development and also to an increased 
size of the fruiting bodies and D3 has an inhibitory effect. 
A 
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Figure 18. Streaming of AX2 and mutant cells. A. Stream formation on a plastic surface 
under phosphate buffer. The time points indicate the occurrence of stream formation. Scale 
bar, 250 µm. B. Time-dependent expression of csA. Cells were collected during development 
in shaking suspension at the indicated time points (in hours) and the lysates analyzed by SDS-
PAGE and western blot. csA was detected by mAb33-294, mAb 47-16-1 detected α-actinin 
which was used as loading control. Since the α-actinin blot was similar for all strains, only the 
α-actinin blot for AX2 is shown.  
 
Streaming and aggregation of the cells depends on the adhesion of the cells to the plastic 
substratum. Upon testing we observed that the mutants exhibited an altered adhesion and 
bound more strongly to the surface than AX2. This could account for the altered streaming 
behavior (Fig. 19). 
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Figure 19. Cell-substrate adhesion. Percentage of cells detached from the surface in 24 well 
plates after shaking at 200 rpm for 1 hour. 
 
2.2.6 CEP161 affects unicellular motility and polarity 
Cell motility is an important feature during growth and development of D. discoideum. 
Dictyostelium cells exhibit an amoeboid type of cell motility. They deform very quickly and 
translocate via rapidly alternating cycles of pseudopod extension and pseudopod retraction in 
response to external signals which are dependent on changes in the actin cytoskeleton. To 
assess the role of CEP161 and mutant proteins for chemotactic motility during aggregation we 
analyzed the motile behaviour of aggregation competent cells and followed the motility of 
cells with time-lapse video microscopy. Mutant cells D1, D2 and D3 consistently displayed a 
reduced speed (~5-8 versus ~16 µm/min for AX2) (Fig. 20A and Table 2). AX2 cells were 
highly elongated and extend pseudopods mainly in the direction of the chemoattractant. The 
mutants displayed a change in morphology and had a more rounded shape in response to 
cAMP signaling (Fig. 20B). In the parameters analysed, directionality did not differ between 
AX2 and mutants CEP161, D1and D2 although D3 mutant showed a decrease, whereas the 
persistence was significantly reduced in the mutants D1, D2 and D3 (Table 2) suggesting that 
CEP161 of D. discoideum plays an important role in chemotaxis as it affects motility and 
polarity.  
A 
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Figure 20. CEP161 affects cell motility and polarity. A. Chemotaxis assay. Analysis of 
speed during migration of aggregation-competent wild type and mutant cells towards the 
chemoattractant cAMP.  B. Images showing migrating aggregation competent cells of AX2, 
CEP161 and D3 cells (scale bar, 50 µm). 
 
Table 2 
Parameter AX2 CEP161 D1 D2 D3 
Speed(µm/min) 16.9 +/- 6.2 15.0 +/- 3.2 7.5 +/- 2.9** 5.0 +/- 2.1** 5.4 +/- 1.3*** 
Persistence 
(µm/min-deg) 
7.2 +/- 4.2 5.4 +/- 1.7** 2.8 +/- 1.3** 2.2 +/- 0.5** 1.8 +/- 0.8*** 
Directionality 0.75 +/- 0.20 0.6 +/- 0.21 0.7 +/- 0.20 0.6 +/- 0.21 0.5 +/- 0.18** 
 
Table 2. Analysis of chemotactic cell motility of AX2 and mutants. Time-lapse image 
series were captured and stored on a computer hard drive at 30-second intervals. Images were 
taken at a magnification of 10X every 6 s. The DIAS software was used to trace individual 
cells along image series and calculate motility parameters. Speed refers to the speed of the 
cell's centroid movement along the total path; directionality indicates migration straightness; 
direction change refers to the number and frequency of turns; persistence is an estimation of 
movement in the direction of the path. Values are mean ± standard deviation of >30 cells from 
three or more independent experiments. The symbol * indicates the significance of the P-
Value (*<0.5, **<0.01, ***<0.001). 
 
2.2.7 CEP161 affects the directed migration of slugs  
During multicellular development cells differentiate into prespore and prestalk cells in the 
aggregate, undergo a morphogenesis and can form a slug which can sense light and migrate in 
a straight path towards the light (Wallraff and Wallraff, 1997). Slugs are polar with a tip at the 
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anterior end consisting of prestalk cells, sensing the light that helps to control their migration 
and phototactic turning. AX2 and CEP161 slugs migrated in a nearly straight path towards the 
light source. D1, D2 and D3 deviated from this path and migrated in an angle towards light. 
Also, the path length appeared shorter in particular for D1 and D2 (Fig. 21A, B). 
A 
 
 
B 
 
Figure 21. CEP161 affects the directed migration of slugs. A. Phototaxis assay. Slugs and 
slug trails were transferred to nitrocellulose filters and stained with amido black. The red 
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arrow indicates the source of light. B. Angle of deviation of the cells when migrating towards 
light. Number of slugs analysed n=4. The symbol * indicates the significance of the P-Value 
(*<0.5, **<0.01, ***<0.001). 
 
2.3 Identification of CEP161 as an interacting partner of the Hippo homolog Hrk-Svk 
To identify interaction partners of CEP161 we carried out immunoprecipitation experiments 
using cells expressing GFP tagged CEP161. The samples were analysed by SDS-PAGE and 
the bands were cut out and further analysed by mass spectrometry. The list of interaction 
partners of CEP161 from mass spectrometry data is shown in appendix I. Among the 
identified proteins we found severin kinase SvkA (DDB_G0286359) as a potential interacting 
partner. SvkA was described as a homolog of human MST3, MST4 and YSK1 kinases 
(Rohlfs et al., 2007). Our detailed sequence analysis showed that it is related to Hippo of 
Drosophila (25.1% identity, 35.7% similarity) and Hippo related Stk3 (MST1) of human 
(34.7% identity; 52.0% similarity). Particularly high homology was observed in the 
serine/threonine protein kinase domain of the proteins (Fig. 22). 
 
 
Figure 22. Sequence alignment for the serine/threonine protein kinase domain of human (Hs) 
MST2 (NP_006272.2), Drosophila (Dm) Hippo (NP_611427.1) and Dictyostelium (Dd) Hrk-
Svk (DDB_G0286359). The numbers indicate the position of the STK domain in the 
respective proteins. Colour code: Red background shows the residues which are strictly 
conserved, yellow background shows similar residues. 
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Given the significance of SvkA to our study and its relation to Hippo, we have renamed it as 
Hippo related kinase-Svk (Hrk-Svk). To further establish Hrk-Svk as an interacting partner 
for CEP161, we performed GST pull down assays with GST-CEP161-D2 and GST-CEP161-
D3 proteins. The D2 protein encompasses the -TuRC domain and a coiled coil domain, D3 
encodes two coiled coil domains (Fig. 23A). Hrk-Svk interacted with the D2 and also the D3 
proteins but not with GST. The precipitate was probed with Hrk-Svk polyclonal antibodies 
(Fig. 23B).  
A 
 
B 
 
Figure 23. Interaction of CEP161 with Hrk-Svk. A. Schematic of the GST tagged CEP161 
polypeptides. B. CEP161 interacts with Hrk-Svk in a pull down assay. The blot was probed 
with pAb for Hrk-Svk. The Ponceau S stained membrane is shown below. 
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The interaction was further investigated by using GST fusion proteins of Hrk-Svk for pulling 
down CEP161. Only the polypetide encompassing the serine threonine kinase domain (STKc) 
interacted with CEP161 locating the binding site in this domain (Fig. 24A, B).  
A 
 
 
B 
 
Figure 24. Interaction of CEP161 with the kinase domain of Hrk-Svk. A. Schematic of 
GST tagged constructs for Hvk-Svk polypeptides. B. Pull down assay showing the interaction 
of Hrk-Svk-E1 interacts with CEP161. The blot was probed with pAb CEP161.The Ponceau S 
stained membrane is shown below. GST-1-323 containing the kinase domain was very 
sensitive to proteolysis. 
 
To investigate the localization of Hrk-Svk we expressed it as GFP tagged protein. Previously 
a cytosolic localization and enrichment at the centrosome was reported for GFP-Hrk-Svk 
(Rohlfs et al., 2007). When we stained GFP-Hrk-Svk expressing cells for CEP161 using mAb 
K83-632-4 we detected CEP161 staining in the center of the strongly GFP positive region 
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near the nucleus showing a yellow puncta in the overlay which indicates a colocalization (Fig. 
25). 
 
Figure 25. CEP161 colocalizes with GFP tagged Hrk-Svk in AX2 cells. CEP161 was 
detected with mAb K83-632-4. Nuclei were stained with DAPI. The boxed area is enlarged at 
the right. Scale bar, 5 µm. 
 
2.4 Interaction of CDK5RAP2 with the mammalian Hippo homolog MST1 
We extended our studies to the mammalian system to probe whether there is a similar 
interaction between components of the Hippo signaling pathway and CDK5RAP2. We used 
Myc tagged CDK5RAP2 and generated N-terminally truncated constructs C1 (residues 1-580) 
and C2 (residues 1-1271) also as Myc tagged polypeptides and expressed them in HeLa cells 
(Fig. 26).  
 
Figure 26. Schematic of Myc tagged constructs of CDK5RAP2. The amino acid residues 
and the domains are indicated. 
 
2.4.1 The N-terminal part of CDK5RAP2 is sufficient for targeting to the centrosome 
The Myc tagged constructs were expressed in HeLa cells and their localisation studied. Myc-
CDK5RAP2 as well as the two truncated proteins was present in a dot near the nucleus which 
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colocalized with the centrosomal marker Pericentrin in immunofluorescence analysis (Fig. 
27). 
 
Figure 27. Immunofluorescence analysis of HeLa cells expressing Myc tagged 
CDK5RAP2 proteins. Myc was recognized by mAb 9E10, the centrosomal marker 
Pericentrin by pAb pericentrin, Nuclei was stained with DAPI. The boxed area is enlarged at 
the right. Scale bar, 10 µm. 
 
The results suggest that the first 580 amino acids which contain the -TuRc domain of 
CDK5RAP2 are sufficient for targeting the centrosome. In some of the C1 and C2 expressing 
cells (0.8%) we noted an abnormal nucleus centrosome ratio (shown for Myc-CDK5RAP2-C1 
with three centrosomes and Myc-CDK5RAP2-C2 with two centrosomes in Fig. 27) 
resembling the data obtained for DdCEP161-D1 and -D2 (Fig. 14A). The nucleus also often 
displayed an irregular shape in the cells expressing Myc-CDK5RAP2-C1 and -C2. 
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2.4.2 Overexpression of Myc tagged CDK5RAP2 
Further experiments were carried out with HEK293T cells ectopically expressing Myc-
CDK5RAP2. The amounts of the Myc tagged protein were 15-fold higher than the one of the 
endogenous CDK5RAP2 (Fig. 28A, B).  
 
A 
 
B 
 
Figure 28. Expression of Myc-CDK5RAP2 in HEK293T cells. A. In the western blot, 
CDK5RAP2 was detected with pAb CDK5RAP2, Myc tagged protein with mAb 9E10, 
GAPDH with mAb GAPDH. B. Quantification of the Myc-CDK5RAP2 in wildtype and Myc-
CDK5RAP2 transfected cells. Signals were analysed using ImageJ. For loading control we 
used GAPDH levels.  
 
2.4.3 CDK5RAP2 interacts with the Hippo homolog MST1 
The Hippo signaling pathway is highly conserved. Whereas most of the Hippo pathway 
components were identified in the fruit fly (Drosophila melanogaster) using mosaic genetic 
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screens, orthologs to these components have subsequently been found in mammals. The core 
component of the Hippo signaling is Hippo in Drosophila or MST1 in Humans. To 
understand the role of CDK5RAP2 in the Hippo signaling pathway, we tested whether 
CDK5RAP2 interacts with MST1, the ortholog of the Dictyostelium Hrk-Svk. We co-
transfected HEK293T cells with Myc-CDK5RAP2 and GFP-MST1 and precipitated GFP-
MST1 using GFP-trap beads. In the precipitate we detected Myc-CDK5RAP2. In 
immunoprecipitation experiments where we used Myc-CDK5RAP2-C1 and -C2, GFP-MST1 
coprecipitated only with CDK5RAP2-C2 indicating that the binding site is located between 
residues 580 and 1271 which encompass the EB1 domain (Fig. 29). 
 
 
Figure 29. CDK5RAP2 interacts with MST1. HEK293T cells were transiently transfected 
with the GFP tagged MST1 and Myc tagged CDK5RAP2 and the GFP-fusion protein 
precipitated using GFP-trap beads. The precipitate (IP) was probed for the presence of Myc 
tagged CDK5RAP2 proteins.  Analysis was with mAb 9E10 to detected Myc tagged proteins 
and mAb mAb K3-184-2 to detect GFP. 
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2.4.4 CDK5RAP2 colocalises with MST1 
The interaction was further analysed by immunofluorescence analysis. HeLa cells transfected 
with Myc-CDK5RAP2 and GFP-MST1 were stained for the Myc tag with mAb 9E10 and 
Pericentrin as a centrosomal marker. GFP-MST1 was present in the cytosol and showed a dot 
like staining near the nucleus. This dot colocalized with the signal for Myc-CDK5RAP2 and 
was recognized by Pericentrin specific antibodies. The immunofluorescence analysis was also 
done with HeLa cells transfected with Myc-CDK5RAP2-C2 and GFP-MST1. A sharp puncta 
staining near the nucleus was observed for Myc staining. It colocalised with the GFP-MST1 
signal which was further recognized by Pericentrin antibodies (Fig. 30A, B). We did not 
observe a co-localisation of the C1 protein with MST1 (data not shown). 
 
A 
 
B 
 
Figure 30. Immunofluorescence analysis to show the localization of CDK5RAP2 and 
MST1. A. Colocalisation of Myc-CDK5RAP2 with GFP-MST1 in HeLa cells. The inset 
shows a magnified image of CDK5RAP2 colocalising with MST1 at the centrosome. The 
boxed area is enlarged at the right. B Colocalisation of Myc-CDK5RAP2-C2 with GFP-
MST1 in HeLa cells. Myc was detected with mAb 9E10, Pericentrin with pAb anti-
pericentrin. Size bar, 10 µm. 
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2.5 CDK5RAP2 is a novel regulator of Hippo signaling 
Next we examined the functional consequences of the MST1-CDK5RAP2 interaction on 
Hippo signaling using an established GAL4-TEAD luciferase reporter system, the repression 
of which reflects activity of the Hippo pathway (Lei et al., 2008; Tian et al., 2010). For the 
luciferase reporter assay, HEK293T cells were seeded in 24-well plates. A mixture of 5× 
upstream activating sequence (UAS)-luciferase reporter, Renilla, and the indicated plasmids 
were cotransfected. Twenty-four hours after cells were transfected, they were lysed, and 
luciferase activity was measured using a dual-luciferase reporter assay system (catalog no. 
E1960; Promega) following the manufacturer's instructions. The luciferase activity was 
measured by a luminometer (model TD-20/20). Transfection efficiency was normalized to 
thymidine kinase-driven Renilla luciferase activity.  
The exogenous TAZ increased GAL4-TEAD activity. The positive control of TAZ expression 
alone expectedly showed a dramatic increase in the luciferase activity, which was normalized 
to 100%. For negative control, TAZ and LATS was co-transfected, since LATS is a potent 
inhibitor of TAZ in the Hippo signaling pathway. Inhibition of TAZ by LATS led to a 
decrease in the relative luciferase activity to 80%. Coexpression of CDK5RAP2 with TAZ 
augmented TEAD4 transcriptional activity to 121% (P-Value < 0.05), in comparison with 
TAZ expression alone. The expression of CDK5RAP2 without TAZ was not sufficient to 
induce TEAD activation (Fig. 31). It behaved like the “no plasmid” control. Although 
CDK5RAP2 was only able to induce a minor activation of TAZ, it points to the fact that 
CDK5RAP2 could have an impact on the Hippo signaling pathway. 
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Figure 31. Luciferase assay. CDK5RAP2 regulates the activity of the transcriptional 
coactivators TAZ. Plasmids encoding the indicated proteins or empty pcDNA6 vector were 
cotransfected in HEK293T cells together with the TEAD reporter plasmids. Coexpression of 
CDK5RAP2 increased the TAZ-dependent signaling to 121% (n = 4; P < 0.05). 
 
 
2.5.1 TAZ interacts with the N-terminal part of CDK5RAP2 
To further understand the role of CDK5RAP2 in the Hippo signaling pathway, we analysed 
for a potential interaction of TAZ with CDK5RAP2 using Flag-trap beads. We also tested if 
the CDK5RAP2 truncated proteins C1 and C2 could also interact with TAZ, which would 
inturn help us to recognize the interacting residues of CDK5RAP2 with TAZ. The 
coimmunoprecipitation showed that Flag-TAZ bound to all three proteins indicating that the 
N-terminal part of Myc-CDK5RAP2 encompassing residues 1-580 is sufficient (Fig. 32). As 
negative control Flag-hnRNPF, which is a ribonuclear protein, was employed. 
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Figure 32. Co-immunoprecipitation assays to study the interaction of CDK5RAP2 with 
TAZ. Myc tagged CDK5RAP2 full length, and the C1 and the C2 proteins were tested. 
HEK293T cells were transiently cotransfected with GFP tagged MST1 and Myc tagged 
CDK5RAP2 proteins. After immunoprecipitation (IP) with GFP trap beads, the resulting blots 
were probed with mAb 9E10 to reveal Myc, mAb K3-184-2 to reveal GFP and pAb anti-Flag 
to reveal Flag.  
 
2.5.2 Ectopic expression of CDK5RAP2 downregulates the expression of TAZ 
Since there appeared to be an interaction of TAZ with CDK5RAP2, we wondered whether 
CDK5RAP2 has an impact on TAZ levels. We first quantified the amount of Flag-TAZ in 
whole cell lysates with wild type untransfected cells as the negative control and Flag-TAZ 
transfected cells as the positive control. We consistently observed a drastic reduction in the 
expression levels of TAZ upon cotransfection with plasmid DNA encoding Myc-CDK5RAP2 
although the amounts of plasmid DNA were identical (Fig. 34A and B).  
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B 
 
 
Figure 33. Ectopic expression of CDK5RAP2 affects the levelsof TAZ. A.Whole cell 
lysate for wild type (WT) HEK293T cells and HEK293T cells ectopically expressing Flag-
TAZ, and cells ectopically expressing Flag-TAZ and Myc-CDK5RAP2. The blot was probed 
with pAb anti-Flag to reveal Flag, mAb 9E10 to reveal Myc and mAb GAPDH to reveal 
GAPDH .  B. Quantification of Flag-TAZ from the whole cell lysate for HEK293T cells 
ectopically expressing Flag-TAZ, and cells ectopically expressing Flag-TAZ and Myc-
CDK5RAP2. Signals were analysed using ImageJ. For loading control we used GAPDH 
levels. (P-value < 0.001).  
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In the Hippo signaling pathway, MST1 mediates the downstream phosphorylation events 
leading to the phosphorylation of TAZ on Ser-89, which creates a phosphoepitope that is 
rapidly engaged by 14-3-3, leading to inactivation and nuclear exclusion of TAZ (Lei et al., 
2008). To directly investigate whether CDK5RAP2 influcences localisation of TAZ, we 
performed further fractionation experiments to reveal the cytoplasmic and nuclear levels of 
Flag-TAZ in cells ectopically expressing Myc-CDK5RAP2. In the cells transfected with Flag-
TAZ, we observed cytoplasmic and nuclear distribution of TAZ. Upon ectopic expression of 
CDK5RAP2, we did not detect a difference in the ratio of the levels of Flag-TAZ in both 
compartments in comparison to the Flag-TAZ alone transfected cells showing that 
CDK5RAP2 does not influence the localisation of TAZ in the cells (Fig. 34). The decrease in 
the Flag-TAZ protein levels was also observed in whole cell lysates of the cells ectopically 
expressing Myc-CDK5RAP2 (Fig. 33).  
 
Figure 33. CDK5RAP2 does not influence the translocation of TAZ to the nucleus. Cell 
fractionation experiments of HEK293T cells expressing the indicated proteins. Please note the 
loading with the Myc-CDK5RAP2 fractions next to each other. 14-3-3 and emerin were used 
as cytosolic and nuclear marker proteins, respectively. 
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The substantial decrease in the protein levels of TAZ encouraged us to perform a quantitative-
RTPCR (q-RTPCR) to examine the transcript abundance of TAZ. We used oligonucleotides 
(see Materials and Methods) which would recognize endogenous TAZ to amplify the 
transcripts in WT untransfected HEK293T cells and cells cotransfected with Myc-
CDK5RAP2. We observed a decrease in the transcript levels of TAZ to ~80% of wild type 
level in cells ectopically expressing CDK5RAP2 (Fig. 35). The results indicate that 
CDK5RAP2 affects transcription of the Taz gene. 
 
 
Figure 35. Effect of ectopically expressed Myc-CDK5RAP2 on endogenous TAZ mRNA 
levels. Quantitative RTPCR (q-RTPCR) to analyse the transcript abundance of endogenous 
TAZ in untransfected HEK293T cells (WT) and cells ectopically expressing Myc-
CDK5RAP2 (P-value < 0.001). 
 
2.5.3 CDK5RAP2 does not influence the interaction of TAZ with 14-3-3 
In the cytoplasm, MST1 and LATS1 regulate the phosphorylation of TAZ at Ser-89. The 
phosphorylated motif of TAZ in turn interacts with 14-3-3 in the cytoplasm leading to the 
cytoplasmic retention of TAZ (Lei et al., 2008). In our coimmunoprecipitation assay we 
observed that TAZ interacts with the N-terminal part of CDK5RAP2. We further performed 
an interaction assay to identify if TAZ-CDK5RAP2 interaction affects the 14-3-3 binding 
affinity of TAZ. HEK293T cells were transfected with Flag-TAZ and then cotransfected with 
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Myc-CDK5RAP2. Flag-trap beads were used to precipitate Flag-TAZ and equal amounts of 
14-3-3 protein were loaded on to the SDS-PAGE gel. The precipitate was probed for co-
immunoprecipitated Flag-TAZ. Our assay did not show any significant difference in the 
interaction levels of TAZ and 14-3-3 between control and cells ectopically expressing 
CDK5RAP2.  Thus it showed that CDK5RAP2 does not influence the interaction of TAZ and 
14-3-3 proteins (Fig. 36). 
 
Figure 36. Interaction of TAZ with protein 14-3-3. Flag-trap beads were used to pull down 
Flag-TAZ from transfected HEK293T cells and the precipitate was probed with pAb specific 
for 14-3-3. 
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Appendix I: Mass spectrometry data of interactions partners for CEP161 
Accession Number Gene ID Score Interaction proved by  
DDB0220454 act13 465.76  
DDB0230070 metK 65.66  
DDB0219924 hgsA 40.87  
DDB0191134 efaAII 38.85  
DDB0191133 abpA 38.78  
DDB0191154 p97 56.58 GST-CEP161-D3 pull down  
DDB0191363 efbA 109.5  
DDB0191380 tuba 18.86 GST-CEP161-D3 pull down 
DDB0191115 corA 46.58  
DDB0232994 psmd11 31.72  
DDB0233951 atp5B 68.33  
DDB0232968 psmC6 44.55  
DDB0238264 hsp-e2 95.03  
DDB0191262 ifdA 31.65  
DDB0267102 nap1 34.58  
DDB0232040 sptA 19.62  
DDB0215382 dscE 69.10  
DDB0201554 abpC 20.56  
DDB0231242 rpl5 20.55  
DDB0230070 metk 17.58  
DDB0229965 sarA 28.46  
DDB0235257 tufM 66.04  
DDB0214930 apm3 13.54  
DDB0191176 svka 34.28 GST-CEP161-D2 and -D3 pull down 
DDB0215016 ddj1 39.16  
DDB0214937 gp130 34.20  
DDB0185207 vatB 22.31  
DDB0191169 tubB 33.19  
DDB0191103 ctxA 27.25  
DDB0233900 cp250 24.25 GST-CEP161-D3 pull down 
DDB0191168 hapB 45.02  
DDB0191175 cadA 22.16  
DDB0219923 comA 25.03  
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3. Discussion 
CEP161 is a novel component of the Dictyostelium centrosome which has a gamma-Tubulin 
Ring Complex (γTuRC) domain and four predicted coiled coil domain and presumably forms 
an elongated molecule. These are the characteristics of a pericentriolar matrix protein. Using 
immunofluorescence analysis we identified CEP161 at the centrosome where it remained 
throughout the cell cycle (data not shown). For this association, the N-terminal part of the 
protein is responsible which harbors the γTuRC domain. The interaction site with its 
centrosomal binding partner CP250 is also located in this region. 
We used mutant cells expressing various CEP161 polypeptides and studied their effect on cell 
size, growth, chemotactic motility and development, since these functions rely on an intact 
centrosome and a functioning microtubule system. The mutant cells had an altered size and a 
disadvantage when grown on a lawn of bacteria. This defective growth of mutants on the 
Klebsiella lawn was reflected by a reduced phagocytic activity of the mutant cells. 
Further we observed changes in the motile behavior with respect to cell speed, motility and 
multicellular slug migration which points to the fact that CEP161 has important roles in cell 
polarity and directed migration. The motility defect could be partially attributed to the strong 
adhesion of the cells to the surface with reduced growth and development for the mutants. For 
a CP250 knockout mutant in which the interaction partner of CEP161 was completely missing 
we had observed similar defects in growth, development and motility (Blau-Wasser et al., 
2009). 
Ectopic expression of CEP161 also affected the localization of the centrosome. In ~80% of 
the cells it was located between 500-800 nm (~42%) and >900 nm (~40%) away from the 
nucleus, in wild type cells ~52% had a distance between 500-900 nm and only 12% a distance 
of >900 nm. Ectopic expression of the shortened D1, D2 and D3 proteins significantly 
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decreased the distance and the majority of the cells (>70%) had their centrosomes in the close 
vicinity of the nucleus (<500 nm). D1 and D2 expression led to an altered nucleus centrosome 
ratio. From our data it appears that the C-terminal residues 115-1381 of CEP161 have an 
impact on the regulation of the nucleus-centrosome distance and more general that the C-
terminus is important for interactions with pathways that impact on cell physiology and 
centrosome biology.  
A cross-talk among various signaling pathways has been implicated in growth and 
development of a cell (Huang et al., 2005; Zhao et al., 2010). We therefore set out to identify 
further partners of CEP161. In a proteomic analysis, we identified Hrk-Svk as interacting 
partner. Hrk-Svk is the homolog of Drosophila melanogaster Hippo and its serine/threonine 
kinase domain shows high similarity to Hippo homologs in higher organisms. Interestingly, 
some of the phenotypes like defects in development and directed slug movement that we 
observed upon ectopic expression of CEP161 and mutant proteins were also detected in Hrk-
Svk mutants (Rohlfs et al., 2007). Hippo signaling is well characterised from Drosophila to 
humans, but the homologs/orthologs of the signaling members are not yet completely 
identified in lower organisms. In amoebozoans, the orthologs of TEAD and MOB1 and 
homolog of MST1 were identified, however no Warts/Lats or Yki/YAP homologs have been 
found (Sebé-Pedrós et al., 2012). Studies on another STE20 like protein, Kinase responsive to 
stress B (KrsB), revealed that it is an important regulator for cellular spreading, adhesion, 
chemotaxis and multicellular development (Artemenko et al., 2012). CEP161 controls various 
functions like growth, development, chemotaxis, adhesion and migration by possibly acting 
through the Hippo signaling pathway in Dictyostelium. 
We could show that the interaction is conserved in mammalian cells as MST1, the Hrk-Svk 
homolog in humans, directly interacts with human CDK5RAP2. We further found that the 
amino acids 580–1271 of CDK5RAP2 are responsible for the interaction with MST1. These 
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amino acids are missing in several MCPH3 mutations which give rise to shortened proteins 
(Kraemer et al., 2011). Recently, it was reported that MST1 signaling controls centrosome 
duplication (Hergovich et al., 2009). Our data suggests that the centrosome duplication by 
MST1 could potentially be mediated through the interaction with CDK5RAP2, since we 
identified abnormal centrosome-nuclei ratio in Hela cells expressing CDK5RAP2-C1 and -C2 
and the data is also consistent with results obtained for the D. discoideum cells expressing the 
CEP161-D1 and D2 proteins. We were also able to show for the first time that TAZ interacts 
with the N-terminal part of CDK5RAP2 (Fig. 35) and that the transcript and protein levels of 
TAZ were influenced by ectopically expressing CDK5RAP2. The interaction of CDK5RAP2 
with TAZ does not affect the downstream interaction of TAZ with 14-3-3. 
Our data for the first time implicates CDK5RAP2 in the control of cell size, growth and 
development and suggests that CDK5RAP2 could potentially be a novel regulator of the 
tumor suppressive Hippo pathway. Our findings further provide a possible explanation for the 
phenotype of small sized brain in microcephaly patients carrying loss-of-function mutations in 
CDK5RAP2. It is reported that loss of Mst1/2 or Lats1/2, or activation of YAP-TEAD in 
neural progenitor cells leads to a marked expansion of neural progenitors, partially due to 
upregulation of cell cycle re-entry and stemness genes, and a concomitant block to 
differentiation by suppressing key genes. Conversely, YAP loss of function results in 
increased cell death and precocious neural differentiation (Cao et al., 2008). Furthermore, 
bone marrow-derived mesenchymal stem cells depleted of TAZ show decreased osteogenesis 
(Hong et al., 2005). In addition, YAP and TAZ proteins are important in brain development 
(Lavado et al., 2013). In neuronal cells, loss of CDK5RAP2 might lead to insufficient TAZ-
dependent proliferative signaling under certain conditions leading to reduced size of the brain. 
This idea is supported by the observation that there is a significant reduction in brain size in 
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MCPH patients with a mutation in CDK5RAP2 leading to a non-functional protein (Bond et 
al., 2005).  
Although further studies are needed to clarify the in vivo importance of the CDK5RAP2 
mediated control of Hippo signaling, our findings may have important consequences. Normal 
organ development requires cellular proliferation to guarantee organ growth and tissue 
regeneration. One of the major downstream components of the Hippo signaling is TAZ, the 
activation of which leads to translocation to the nucleus to transcribe its target genes to 
promote cell proliferation, development and differentiation (Nishioka et al., 2009; Zhang et 
al., 2009a). Significantly, TAZ is overexpressed in many human tumors which include breast 
cancer samples and papillary thyroid carcinoma tissues (De Cristofaro et al., 2011), whereas 
attenuation of TAZ activity tends to have the opposite effect in the central nervous system 
(Lavado et al., 2013). In addition, Taz knock out mice were readily identified by their smaller 
size compared to their normal littermates (Tian et al., 2007). Furthermore, conditional 
knockout mouse of Mst1 and Mst2 in a variety tissues were generated and severe context-
dependent phenotypes were observed with higher proliferation in liver and heart, but a 
reduced growth in pancreas (Zhou et al., 2009; Heallen et al., 2011; George ., 2012). Our data 
also show that CDK5RAP2 can control the activity of the Hippo pathway by regulating the 
transcript levels of TAZ, which is the master regulator of this pathway. The antagonistic 
regulation of TAZ by CDK5RAP2 suggests that it may act as a novel regulator of Hippo by 
controlling the proliferative signaling, which may be critical for growth and development of 
the brain. Our model shows that CDK5RAP2 could regulate the Hippo pathway at multiple 
sites. The EB1 domain of CDK5RAP2 interacts with MST1, whereas the N-terminal part 
which includes the γTuRC and SMC domain interacts with TAZ. However, CDK5RAP2 
could possibly down regulate the transcription of the Taz gene by a non-canonical Hippo 
signaling pathway (Fig. 37).  
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Our Dictyostelium CEP161 and human CDK5RAP2 studies support the hypothesis that the 
Hippo pathway could be antagonistically regulated by CDK5RAP2, affecting proliferation, 
size, growth, development, polarity and migration. Thus, lack of CDKRAP2 in microcephaly 
patients may deregulate the activity of the Hippo signaling pathway, resulting in 
antiproliferative cellular signaling and thus, leading to reduced or insufficient growth. This 
might explain some aspects of the phenotype of MCPH. Understanding the degree to which 
this mechanism plays a role in MCPH in vivo will require further studies using animal models 
and patient cells. 
 
 
 
Figure 37. Model for CDK5RAP2 role as a novel regulator in the Hippo signaling 
pathway. CDK5RAP2 interacts with core Hippo components MST1 and TAZ and also 
downregulates the transcription levels of TAZ. CDK5RAP2 influence on Hippo pathway 
components in vertebrates is shown in various colors, with black pointed for direct 
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interactions and red blunt arrowheads indicating inhibitory interactions. CDK5RAP2 directly 
interacts with MST1 and TAZ. The interaction with TAZ does not influence its interaction 
with 14-3-3. Red dashed lines indicate unknown mechanisms of TAZ depletion in transcript 
levels by CDK5RAP2, whereas black dotted lines indicate translocation of TAZ to the 
nucleus. The blue pointed arrow indicates the functions affected. Abbreviations: MST1, 
Mammalian sterile 20 like 1; LATS, Large tumor suppressor; TAZ, transcriptional co-
activator with PDZ- binding motif; TEAD, TEA domain protein. 
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4. Material and methods 
Standard molecular biology techniques were performed as described in Sambrook et al., 1989. 
Light and heavy instruments used were properties of the Department. Standard laboratory 
materials and reagents were obtained from local suppliers. 
  
4.1    Kits 
NucleoSpin Extract 2 in 1            Macherey-Nagel 
M-MLV reverse transcriptase RNase H Minus-kit   Promega 
Quick Change Site-Directed Mutagenesis kit                            Stratagene 
pGEM-T easy Vector kit                                                          Promega 
Pure Yield Plasmid System                                                      Promega 
 
4.2     Enzymes, antibodies and antibiotics 
 
4.2.1   Enzymes for molecular biology: 
Taq-polymerase                                                                 Promega 
T4 DNA ligase                                                                    Boehringer    
Thrombin                                                                      GE Healthcare 
Pfu DNA polymerase                                                         Promega    
GoTaq qPCR master mix      Promega 
Alkaline phosphatase                                                       Roche 
Restriction endonuclease                                                  New England Biolabs 
Ribonuclease A                                                                Sigma 
Trypsin        Invitrogen     
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4.2.2 Primary antibodies 
Mouse monoclonal anti- α-actinin mAb 47-16-8             (Schleicher et al., 1984) 
Mouse monoclonal anti-csA mAb 33-294                        (Berthold et al., 1985) 
Mouse monoclonal anti-cap32 mAb 188-19-95                  (Haus et al., 1993) 
Mouse monoclonal anti-GFP mAb K3-184-2                    (Noegel et al., 2004) 
Mouse monoclonal anti-comitin mAb 190-340-8    (Weiner et al., 1993) 
Mouse monoclonal anti-CEP161 mAb K83-632-4   This study 
Mouse monoclonal anti-myc 9E10     Santa Curz Biotech 
Mouse monoclonal anti-CP250 mAb K68-332-3   (Blau-Wasser et al., 2009) 
Mouse- monoclonal anti-emerin (4G5)     Abcam 
Mouse- monoclonal anti-GAPDH     Sigma 
Rabbit polyclonal anti-GST                                               (Xiong et al., 2008) 
Rabbit polyclonal anti-CDK5RAP2                                     Millipore 
Rabbit polyclonal anti-14-3-3                                                Sigma 
Rabbit polyclonal anti-Flag                                                Sigma 
Rabbit polyclonal anti-CEP161                                            This study 
Rat-anti-α-tubulin (YL1/2)      (Kilmartin et al., 1982) 
Rabbit-anti-pericentrin       Abcam 
Rabbit polyclonal anti-14-3-3      Santa Cruz Biotechnology 
Rabbit polyclonal anti-Hrk-Svk     (Rohlfs et al., 2007) 
 
4.2.3 Secondary antibodies 
Anti-mouse IgG, Alexa488-conjugated    Sigma 
Anti-mouse IgG, Alexa568-conjugated    Sigma 
Anti-goat IgG, Alexa568-conjugated    Sigma 
Anti-mouse IgG Alexa Fluor 488     Invitrogen 
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Anti-mouse IgG POD       Sigma 
Anti-rabbit IgG POD        Sigma 
Anti-rat IgG POD       Sigma 
 
4.2.4   Antibiotics  
Ampicillin                                                                 Sigma 
Kanamycin        Sigma 
Blasticidin S                                                                Biomedicals 
Dihydrostreptomycinsulphate                                           Sigma 
Tetracyclin                                                                         Sigma 
Gentamicin                                                                          Sigma        
G418                                                                                    Sigma 
Penicillin/Streptomycin      Biochrom    
 
4.3    Media and Buffers 
All solutions and media used in the course of these experiments were prepared with deionized 
water from a pure water source in the laboratory. All other buffers and solutions which were 
not mentioned here are stated in the methods. 
 
4.3.1 Buffers and Solutions 
GST-fusion protein elution buffer, pH 7.2 
50 mM Tris/HCl, pH 7.2 
100 mM NaCl 
10 mM reduced glutathione 
0.2 % Tween-20 
10 mM DTT 
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10 x NCP-buffer, pH 8.0 
12.1 g Tris  
87.0 g NaCl  
5.0 ml Tween 20  
2.0 g NaCl  
Made up to 1 litre with deionised water, pH adjusted with HCl 
50 x Tris/Acetate buffer (TAE), pH 8.0  
242 g Tris  
57.1 ml 16.6 M Glacial acetic acid  
100 ml 0.5 M EDTA  
Made up to 1 litre with deionized water 
TBS lysis buffer, pH 7.2 
50 mM Tris/HCl, pH 7.2 
100 mM NaCl 
TE-buffer, pH 8.0 
10 mM Tris/HCl, pH 8.0  
1 mM EDTA 
 
4.3.2   Bacterial medium and agar plates 
LB-medium (Sambroock et al., 1989) 
10 g/l Bacto-Tryptone 
5 g/l Yeast Extract 
5 g/l NaCl  
pH was adjusted to 7.0 with 5 M NaOH and the volume brought to 1 litre with deionised 
water and then autoclaved. 
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Ampicillin-LB-agar plates 
For the preparation of LB-agar plates, 0.9% (w/v) agar was added to LB-medium. After 
autoclaving and cooling to ~55
o
C, 100 mg/l ampicillin was added. Storage was at 4
o
C.  
To prepare plates with ampicillin/IPTG/X-Gal, 10 µl of 1M IPTG and 50 µl of 20 mg/ml X-
Gal was spread over the surface of LB-Amp-Plates and allowed to absorb for at least 30 
minutes at 37
o
C prior to use.  
 
4.3.3   Yeast medium 
YEPD-medium  
20 g Difco-Peptone  
10 g Yeast Extract                 Made up to 1 litre with deionized water and then autoclaved 
YEPD-agar plates  
20 g Difco-Peptone  
10 g Yeast Extract  
18 g Agar-Agar  
Made up to 1 litre and then autoclaved 
100x L-Adenine solution      
200 mg of L-Adenine dissolved in 100 ml H2O. Dissolution was aided with addition of drops 
of HCl and then sterile filtered.                                                                    
100x L-Tyrosine solution 
300 mg of L-Tyrosine dissolved in 100 ml H2O. Dissolution was aided with addition of drops 
of NaOH and then sterile filtered.                                                                  
100x L-Histidine solution           
200 mg of L-Histidine dissolved in 100 ml H2O and then sterile filtered.                          
100x L-Leucine solution 
200 mg of L-Leucine dissolved in 100 ml H2O and then sterile filtered.    
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100x L-Tryptophan solution  
200 mg of L-Tryptophan dissolved in 100 ml H2O and then sterile filtered. 
100x L-Uracil solution 
200 mg of L-Uracil dissolved in 100 ml H2O. Dissolution was aided by slightly warming 
solution before it was sterile filtered. 
50x Drop-out Solution 
1,500 mg Isoleucine  
7,500 mg Valine  
1,000 mg Arginine  
1,500 mg Lysine  
1000 mg Methionine  
2,500 mg Phenylalanine  
10,000 mg Threonine 
Filled up to 1 litre and then sterile filtered 
20x Drop-out Solution 
20 ml 50x Drop-out solution                                                                                                      
10 ml 100x L-Uracil                                                                                                                   
10 ml 100x L-Tyrosine                                                                                                                
10 ml 100x L-Adenine  
1 M 3-Amino-1, 2, 4-triazol solution (3AT) 
8.4 g 3-Amino-1, 2, 4-triazol dissolved in 100 ml deionised H2O and then sterile filtered. 
Composition of the Yeast Selection Plates and Selection Medium 
  SD/-Leu/-Trp     SD/-Leu/-Trp/ 
  -His/+3AT 
Yeast Nitrogen Base (g)        6.7         6.7 
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Agar-Agar (g)        20         20 
Water (ml)        770         745 
20% Glucose solution (ml)        100         100 
20x Drop-out solution (ml)        50         50 
100 x L-Histidine (ml)        10   
100 x L-Leucine (ml)         -   
100 x L-Tryptophan (ml)         -   
1M 3AT Solution (ml)                     25  
 
Yeast selection media were prepared but without the addition of the 20 g Agar to the 
preparations. To test for protein interactions, transformants on the SD /-Leu /-Trp plates were 
transferred to the SD /-Leu /-Trp /-His /+3AT plates. After 6-8 days, the colonies which grew 
were used to perform β-galactosidase activity staining.  
 
4.4   Media and buffers for Dictyostelium cultures 
AX2-medium, pH 6.7 (Claviez et al., 1982) 
7.15 g Yeast extract  
14.3 g Peptone  
18.0 g Maltose  
0.486 g KH2PO4  
0.616 g Na2HPO2 x H2O  
Made up with H2O to 1 Liter 
Soerensen phosphate buffer, pH 6.0 (Malchow et al., 1972) 
2 mM Na2HPO4  
14.6 mM KH2PO4 
 
73 
 
Phosphate-agar plates, pH 6.0 
9 g agar made up with Soerensen phosphate buffer pH 6.0 to 1 Litre  
Water agar plates 
1% agar in Water  
4.5  Bacteria, D. discoideum, and yeast strains 
Bacteria  
E.coli (XL1 blue) (Bullock et al., 1987)                                                                    
E.coli (BL21) (Studier and Moffatt, 1986)                                                                         
D. discoideum 
AX2-214, also known as AX2 is a derivative of NC4 wild isolate (Raper, 1935) which can 
grow axenically. 
Yeast strain 
Saccharomyces cerevisiae Y190 (His3 and lacZ reporter genes) (Johnston et al., 1991; Harper 
et al., 1993). 
 
4.6   Oligonucleotides 
Oligonucleotides used for PCR (Polymerase Chain Reaction) were purchased from Sigma-
Genosys in Steinheim. 
Cep161 1F  GGATCCATGAATGGATGGGGAGAAAGTGACG 
Cep161 2320R GGATCCGTAGATCTTCCTTCTCATCGAATAGC 
Cep161 2293F GGATCCTTGCTATTGGATGAGAAGGAAGATCTAC 
Cep161 3342R CCCGGGGATATCAGGATTTAAAGTTATTAAAGATGAAG 
Cep161 3314F GGATCCTCATCTTTAATAACTTTAAATCCTGATATC 
Cep161 4143R CCCGGGTTTTATTTGTTGTTTAAGTAAATTTAATTGTTTG 
For site directed mutagenesis 
Cep161 3295R GAGCTAAAGAGATGGTCATGGTTCTTTTGGTTGTGG 
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Cep161 2290R CCTTCTCATCCAATAGCAATTACTGTTGTTGTTGATTAGCC 
 
For q-RTPCR 
Taz 694F  AGAGAATGAGGGGAAAGGTGTT 
Taz 1023R  CCGATCAGCACAGTGATTTTCT 
 
4.7 Dictyostelium vector construction and transfection 
For expression of CEP161 GFP fusion proteins in Dictyostelium, sequences encompassing 
amino acids 1-1114 corresponding to nucleotides 1-3340 (GFP-CEP161-D1), amino acids 1-
763 corresponding to nucleotides 1-2290 (GFP-CEP161-D2) and amino acids 763-1114 
corresponding to nucleotides 2290-3340 (GFP-CEP161-D3) were cloned into pBsr GFP N2 
vector (Blau-Wasser et al., 2009). Expression was under the control of the constitutively 
active D. discoideum actin15 promoter. A PCR-mediated site-directed mutagenesis 
(QuikChange Site-Directed Mutagenesis Kit, Stratagene) was used to generate mutations in 
CEP161 to produce the GFP-CEP161-D1 and GFP-CEP161-D2 plasmids to yield truncated 
proteins. The mutations were confirmed by sequencing. The plasmids were introduced into 
AX2 cells by electroporation using a Biorad electroporator Gene Pulser Xcell (Biorad, 
München, Germany) according to the protocol supplied (Faix et al., 2004). Cells expressing 
GFP tagged proteins were identified by immunofluorescence analysis and western blotting. 
 
4.8 Cloning of CEP161 genomic DNA and expression of recombinant proteins 
For expression of recombinant CEP161-D2 (1-763aa) and -D3 (763-1114aa) as glutathione S 
transferase (GST) fusion proteins in E. coli, genomic DNAs were respectively cloned into 
pGEX-4T-1 vector (GE Healthcare Life Sciences). The Hrk-SvkA-E1 (1-323aa) and -E2 
(290-478aa) constructs cloned in to pGEX-4T-1 vector were kindly provided by Prof. Michael 
Schleicher, Ludwig-Maximilians-University, München, Germany. E. coli strain XL1 Blue 
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was used for expression of the GST fusion proteins. Induction of protein expression was with 
0.25 mM isopropyl β-D-thio-galactoside (IPTG) when an OD600 of 0.8 was reached. Cells 
were further cultured at 30ºC for 3 hours. They were harvested, lysed in 50 mM Tris/HCl, pH 
7.4, 100 mM NaCl, supplemented with Protease inhibitors (0.5 mM PMSF, 1mM 
Benzamidine and Complete (Roche) and 1mM DTT with an EmulsiFlex cell homogenizer 
(Avestin Europe GmbH, Mannheim, Germany). Lysates were separated into soluble and 
insoluble fractions by centrifugation at 18,000g. The fusion proteins from the soluble fraction 
were purified using GST-Sepharose beads (GE Healthcare). 
 
4.9 Growth and development  
Growth and development were done as described (Khurana et al., 2002). Cells were either 
grown on a lawn of K. aerogenes on SM agar plates, on a lawn of E. coli B12 on NA-agar or 
cultivated in shaking suspension (160 rpm) or in a submerged culture at 21-23°C in axenic 
medium (Harloff et al., 1989). Development was initiated by plating 5 x 10
7
 cells which were 
washed twice with Soerensen phosphate buffer (17 mM Na
+
/K
+
 phosphate, pH 6.0) on 
phosphate agar plates and monitored. Development was also followed for cells starved in 
Soerensen phosphate buffer in shaken suspension (1 x 10
7
 cells/ml; 160 rpm at 22ºC) or in 
petri dishes. Mutants were maintained in the presence of appropriate antibiotics (3-5 µg/ml 
Blasticidin) (MP Biomedicals Inc., Eschwege, Germany). The following strains have been 
used; AX2-214 (wild type) (Noegel et al., 1985), AX2 expressing GFP tagged fusion proteins 
CEP161, D1, D2 and D3.   
 
4.10 Generation of Antibodies 
Mouse monoclonal antibodies were generated against CEP161-D2 (amino acids 1-763) as 
described (Xiong et al., 2008). For immunization of mice the GST-part was removed by 
thrombin cleavage. The identity of the CEP161 polypeptide was confirmed by mass 
76 
 
spectrometry. mAb K83-632-4 was used in this study. It recognized the bacterially produced 
recombinant protein and the endogenous protein in immunofluorescence. Rabbit polyclonal 
antibodies specific for CEP161 were generated against a GST fusion protein containing the 
amino acids 763-1114 (CEP161-D3). Polyclonal antibodies were generated by Pineda, Berlin, 
Germany. The pAb CEP161 recognized the recombinant and the endogenous protein in 
western blots of whole cell lysates. The polyclonal antibodies did not show a specific signal in 
immunofluorescence. For cleavage of the D3 protein from GST-Sepharose beads, the beads 
bound GST fusion proteins were washed 5 times with cleavage buffer (20 mM Tris/HCl, pH 
7.4, 150 mM NaCl and 0.2 % Sarkosyl). Beads were then re-suspended in cleavage buffer and 
3-5 U Prescission protease /mg fusion protein were added to the beads and incubated with 
little agitation at 4
0
C overnight. As CEP161-D3 was released from the beads together with 
GST, we next performed an anion exchange chromatography step in order to separate the 
proteins. For this the protein solution was dialyzed against 20 mM Tris/HCl, pH 8.0, and 1 
mM EDTA overnight before loading onto a DE-52 Sephadex column which had been 
calibrated with 50 mM Tris/HCl, pH 8.0, 1 mM EDTA. The protein was eluted with 1 M 
NaCl and the eluate dialyzed and analyzed by SDS-PAGE.  
 
4.11   Immunofluorescence analysis for D.discoideum cells. 
Immunofluorescence study was performed as previously described (Blau-Wasser et al., 2009). 
Briefly, cells were transferred onto coverslips in Petri dishes and fixed by ice-cold methanol 
(5 min, 20 °C). Cells were treated twice for 15 min (room temperature) with blocking solution 
(1x PBS containing 0.5% (wt/vol) BSA and 0.1% (vol/vol) fish gelatin). The appropriate 
antibodies were diluted in the blocking solution and applied on the cells for 1 h at room 
temperature; the excess of antibodies was removed by washing with the blocking solution 
before the 1 h incubation with the corresponding secondary antibodies. Analysis of fixed was 
done by laser scanning confocal microscopy using a Leica TCS SP5 microscope.  
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4.12  Pull down and immunoprecipitation assays for D.discoideum 
For pull down and immunoprecipitation experiments, D. discoideum cells were lysed in 50 
mM (10 mM for immunoprecipitation assay) Tris/HCl, pH 7.4, 150 mM NaCl, 0.5% NP40, 
supplemented with protease inhibitor cocktail (Sigma), 0.5 mM PMSF, 0.5 mM EDTA, and 1 
mM Benzamidine by passing them through a 25G syringe (10-20 strokes) and incubated with 
agitation (1000 rpm) for 15 min at 4ºC (to ensure complete cell lysis) followed by a 
centrifugation step at 16,000 rpm for 10 min. The supernatants were either incubated with 
GST and GST-fusion proteins respectively or with GFP-trap beads (ChromoTek, Martinsried, 
Germany). After incubation for 3 h while GST beads were washed three times with wash 
buffer (50 mM Tris/HCl, pH 7.4, 150 mM NaCl, protease inhibitor cocktail, 0.5 mM PMSF, 
0.5 mM EDTA, 1 mM Benzamidine), GFP-trap beads were washed with a different wash 
buffer (10 mM Tris/HCl pH 7.4, 50 mM NaCl, protease inhibitor cocktail, 0.5 mM PMSF, 0.5 
mM EDTA, 1 mM Benzamidine). The beads were resuspended in SDS sample buffer, 
incubated at 95ºC for 5 min and the proteins separated by SDS-PAGE and analyzed by 
western blot.  
 
4.13 Analysis of D. discoideum nuclear and centrosome abnormalities 
The centrosome was stained with mAb K83-632-4 for CEP161; DNA of the fixed cells was 
stained with DAPI. Confocal microscopy images were taken and nuclei and centrosome 
number and the distance between centrosome and nucleus determined. The centrosome-
nucleus distance was measured using the scale bar in the LAS-AF-LITE software for confocal 
microscopy imaging. 
 
4.14 D. discoideum cell adhesion assay 
To analyse cell-substrate adhesion a substrate detachment assay was carried out. A total of 
1×10
6
 cells in growth medium were added per well (24 well plates, Costar) and incubation 
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was for four hours at 22°C. Then the plates were shaken on a gyrotary shaker at 60, 120 and 
200 rpm for one hour each. The number of detached cells was counted in a hemocytometer. 
The total number of cells was determined after resuspension of all cells and the percentage of 
detached cells calculated.  
 
4.15  D. discoideum cell migration studies 
This analysis was done as previously described (Blau-Wasser et al., 2009; Müller et al., 
2013). Briefly, growing cells were plated in a chamber (ibidi GmbH-Martinsried, Germany) 
and random motility was followed. Images were recorded at intervals of 6 s using a Leica 
DM-IL inverse microscope (Deerfield, IL; 40x objective) and a conventional CCD video 
camera and analyzed using Dynamic Image Analysis Software (DIAS, Soll Technologies, 
Iowa City, IA). The DIAS software was used to trace individual cells along image series and 
automatically outlined the cell perimeters and converted them to replacement images from 
which the position of the cell centroid was determined. Speed and change of direction were 
computed from the centroid position. For processing images, Corel Draw version 11 and 
Adobe Photoshop were used.  
 
4.16 Phototaxis assay                                                                     
Phototaxis assays were essentially performed as described earlier (Khaire et al., 2007). For 
phototaxis, cells from shaking suspension culture were washed with Soerenson buffer and 
5×10
5
 cells were placed in the center of a water agar plate. The cells were allowed to adhere 
on to the agar surface and incubated in a dark chamber with a light source only at one end of 
the plate. Slugs were allowed to form and migrate towards light. After 48 h, slugs and slime 
trails were transferred onto nitrocellulose filters and stained with Amido Black. The filters 
exhibiting the stained slime trails were used to determine the distance travelled by the slugs 
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towards the source of light from the point of application. The angle of deviation of the slugs 
was measured with the software Kreiswinkelmesser.  
 
4.17   Yeast Two-Hybrid Interaction             
For the yeast two-hybrid screen, the full-length cDNAs of D. discoideum CP250 were cloned 
in frame into the yeast pAS2-1 vector (Clontech), resulting in fusion to the GAL4-DNA-BD 
(BD, binding domain). cDNA corresponding to 1- 763aa and 763 to 1114 aa of DdCEP161 
was cloned into the yeast pACT2 vector (Clontech) resulting in a fusion to the GAL4-DNA-
AD (AD, activation domain). Yeast Y190 strain which has His3 and lacZ reporter genes was 
used for this assay. 
Candidate colonies expressing interacting proteins were screened by plating on SD/-Leu/-
Trp/-His/+3AT plates after which membrane colonies-lift β-galactosidase activity assay was 
performed according to the MATCHMAKER Y2H system manual. Briefly, colonies on SD/-
Leu/-Trp/-His/+3AT selection plates were transferred to a Nitrocellulose membrane (Protran 
BA 85) by placing the membrane over colonies on selection plates for 20 min. The filter was 
carefully lifted off the agar plates and transferred (with colonies facing up) to a pool of liquid 
nitrogen for 10 sec. The frozen filter was then allowed to thaw at RT and placed on a 
Whatman filter paper presoaked in freshly prepared X-Gal solution (60 mM Na2HPO4, 40 mM 
NaH2PO4, 10 mM KCl, 1 mM MgSO4, pH 7.0, 50 mM β-mercaptoethanol, X-Gal (1 mg/ml 
final concentration)) and incubated at 30
o
C and checked between 1 to 6 h for the appearance 
of blue colonies.   
 
4.18 Mammalian cell culture, constructs and transfection 
HeLa (human epithelial carcinoma) and Hek293T (Human embryonic kidney) cell lines were 
grown in high glucose Dulbecco’s Modified Eagle’s Medium (DMEM, Sigma) supplemented 
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with 10% FBS, 2 mM glutamine, and 1% penicillin/streptomycin. All cells were grown in a 
humidified atmosphere containing 5% CO2 at 37
0
C.  
Plasmidsfor mammalian cell transfection studies 
Myc-CDK5RAP2    Addgene plasmid 41152 
Myc-CDK5RAP2-C1  (1-580aa)  This study 
Myc-CDK5RAP2-C2  (1-1271aa)  This study 
GFP-MST1     B.Schermer (CECAD, Cologne, Germany) 
Flag-TAZ  M. Yaffe (Massachusetts Institute of Technology, 
Boston, MA)  
Lats  M. Yaffe (Massachusetts Institute of Technology, 
Boston, MA)  
pGBD-Hyg-Luc and pGal4-TEAD  Biomyx, San Diego, USA 
The cells were transfected using the reagent Polyethylenimine (PEI) Polysciences, Inc. 
(Catalogue No 23966-2). PEI condenses DNA into positively charged particles, which bind to 
anionic cell surface residues and are brought into the cell via endocytosis. For transfection, 
PEI and the DNA constructs are used in the ratio of 1:3. The mixture is incubated at room 
temperature in serum free DMEM media for 15 minutes and added directly on to the cells.  
 
4.19 Immunofluorescence                         
Immunofluorescence was done as described (Taranum et al., 2012). The cells were grown on 
12 mm coverslips and fixed with 3% paraformaldehyde (5 min, RT), followed by 
permeabilization with 0.5% Triton X-100 for 3 minutes (RT). Subsequently, the fixed cells 
were washed three times with 1x PBS and  incubated for 15 minutes with blocking solution 
(1x PBG: PBS containing 5% BSA and 0.045% fish gelatine in 1x PBS, pH 7.4). After 
blocking, primary antibodies were diluted in PBG and incubated 1 h (RT) or overnight (4°C). 
The cells were washed three times for 5 minutes each, the samples were incubated with 
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appropriate secondary antibodies conjugated to Alexa 488/568 (1:1.000 diluted in PBG) for 
one hour at room temperature. Nuclear DNA was stained with 4’,6-Diamidino-2’-
phenylindole (DAPI, Sigma). Finally the coverslips were mounted on glass slides with 
gelvatol. Imaging was done by confocal laser scanning microscopy (Leica TCS-SP5). Images 
were processed using TCS-SP5 software.   
3% Paraformaldehyde 
3% PFA is dissolved in 1x PBS at 55
0
C with stirring at room temperature for overnight. 
10x PBG 
10x PBS 
5% BSA 
0.45% Fish Gelatin  
10x PBS 
80 g NaCl 
2 g KCl 
14.4 g Na2HPO4 
2.4 g KH2PO4 
Adjust the pH to 7.4 with HCl and make up the volume to 1L with H2O  
 
4.20 Immunoprecipitation                       
For immunoprecipitation experiments, HEK293T cells were lysed in 10 mM Tris/HCl, pH 
7.4, 50 mM NaCl, 0.5% NP40, protease inhibitor cocktail, 0.5 mM PMSF, 0.5 mM EDTA, 1 
mM Benzamidine and incubated for 30 min at 4ºC (to ensure complete cell lysis) followed by 
a centrifugation step at 16,000 rpm for 10 min at 4ºC. The supernatants were either incubated 
with GFP-trap beads (ChromoTek, Martinsried, Germany) or with Flag-trap beads (Sigma, 
st.Louis, USA, Catalog Number A2220) for 2 hours at 4ºC. GFP-trap beads were washed with 
a different wash buffer (10 mM Tris/HCl pH 7.4, 50 mM NaCl, protease inhibitor cocktail, 
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0.5 mM PMSF, 0.5 mM EDTA, 1 mM Benzamidine). The beads were resuspended in SDS 
sample buffer, incubated at 95ºC for 5 min and the proteins separated by SDS-PAGE and 
analyzed by western blot.  
    
4.21 Fractionation of cytoplasmic and nuclear proteins          
HEK293T cells were transfected with Flag-TAZ and Myc-CDK5RAP2. The transfected cells 
were suspended in 1 ml hypotonic buffer (10 mM HEPES, pH 7.9, 1.5 mM MgCl2, and 10 
mM KCl, PIC) followed by centrifugation (1000 rpm, 20 s, 4°C). Pellets were again 
resuspended in 1 ml hypotonic buffer. Cell suspensions were lysed through a needle (0.4 mm) 
for 10 times and incubated on ice for 10 min. Nuclear and cytoplasmic fractions were 
separated by centrifugation (1000 rpm, 10 min, 4°C). Pellets (nuclear fraction) were washed 
with 1 ml PBS (1000 rpm, 6x10 min, 4°C). The samples were boiled in SDS sample buffer 
(95°C, 5 min) and analyzed by western blot.  
 
4.22 Protein extraction from mammalian cells         
Mammalian cells were trypsinised and washed with ice cold 1x phosphate buffered saline 
(PBS) plus protease inhibitor (DTT, Benzamidine and PMSF at 1 mM each). After 
centrifugation at 15,000 rpm at 4°C the pellet was resuspended in lysis buffer (50 mM 
Tris/HCl, pH 7.5, 50 mM NaCl, 1% Nonidet P-40, PIC and further protease inhibitors DTT, 
Benzamidine and PMSF. The sample was denatured in 5x SDS sample buffer at 95°C for 5 
minutes. The samples were used for SDS-PAGE and western blot analyses.           
5 x SDS-Sample buffer 
5 x SDS loading buffer  
2.5 ml 1M Tris/HCl, pH 6.8  
4.0 ml 10% SDS  
2.0 ml Glycerol  
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1.0 ml 14.3 M ß-Mercaptoethanol 
200 μl 10% Bromophenol blue 
 
4.23 Western blotting                                   
For immunoblotting, equal amounts of total cell protein were separated by SDS-PAGE (12%, 
3%-12% gradient gel). After the SDS-PAGE, sheets of Whatman filter papers and 
nitrocellulose membranes were pre-cut to the gel dimensions. The Whatman papers, sponges, 
membranes, and gels were immersed in transfer buffer for 5 min. For protein transfer, semi-
dry (45 min, 12 Volt) or wet blotting (overnight, 15 Volt) transfer was used. Subsequently, the 
membrane was blocked with 12.5 ml 1% blocking solution under constant shaking for 1 h. 
After blocking, the membrane was incubated with primary antibody solution for either 
overnight (+4°C) or 1 h (RT). The membrane was washed three times with NCP for 15 min 
and incubatedwith the corresponding appropriate horseradish peroxidase coupled secondary 
antibodies (1:10.000) for 1 h, and the membrane was washed three times with NCP. Antigen-
antibody complexes were detected by using the ECL western blotting detection solution. The 
protein bands were visualized using X-ray films. After imaging, the membrane was stripped 
with 0.2 M NaOH for 15 min. The stripped membrane was washed twice with NCP for 15 
min. After washing the membrane, the membrane was blocked with blocking solution for 1 h 
at room temperature and used for antibody incubation. 
Transfer buffer SDS-gels     
48 mM Tris/HCl, pH 8.3     
39 mM glycine       
10% ethanol   
Ponceau staining solution  
2 g Ponceau S  
100 ml 3% Trichloroacetic acid  
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0.04% Tween 20 
ECL solution 
2 ml 1 M Tris/HCl (pH 8.0) 
200 μl Luminol (0.25 M in DMSO) 3-aminonaphthylhydrazide 
89 μl (0.1 M in DMSO) p-coumaric acid 
18 ml dH2O 
6.3 μl 30% H2O2 
Blocking solution 
4% milk-powder in TBS-T 
 
4.24 Luciferase assay            
The luciferase reporter plasmid (pGBD-Hyg-Luc) was transfected together with an activator 
plasmid (pGal4-TEAD), pGL4.74 (Promega) for normalization, and the indicated expression 
plasmids (TAZ, CDK5RAP2, Lats1, and the control empty pcDNA6) into HEK293T cells in 
a 96-well format using Lipofectamine LTX (Invitrogen) as a transfection reagent. The total 
amount of DNA was always adjusted with empty pcDNA6. Renilla luciferase and firefly 
luciferase activities were measured by using a reporter assay system (Dual Luciferase; 
Promega) in a luminometer (Mithras LB 940; Berthold) 24 h after transfection. For the Lats1 
siRNA experiment, the indicated plasmids and siRNAs were cotransfected into HEK293T 
cells. The measurement was performed 48 h after transfection. Transfections and 
measurements were performed in triplicates for each single experiment, and each experiment 
was repeated at least three times. Error bars shown in the figures represent SEM. P-values 
were calculated using an unpaired Student’s t test. Equal expression of the transfected 
proteins was confirmed by Western blot analysis.   
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4.25 RNA isolation and cDNA generation for quantitative RT-PCR analysis  
For RT-PCR, total RNA was extracted for gene expression analysis using TRIzol 
(Invitrogen). Briefly, the cells were trypsinised and centrifuged in ice cold PBS (1200 rpm, 5 
min). The pellet was suspended in 1 ml TRIzol (50-100 mg cells) and incubated for 5 min 
(RT). Subsequently, chloroform (for each ml of TRIzol 200 μl) was added, mixed and 
incubated at RT for 2-3 min followed by centrifugation (12,000 g, 15 min). The aqueous 
phase was precipitated with isopropanol (for each ml of solution 500 μl isopropanol) and 
incubated for 10 min (RT) and centrifuged (12,000 g, 10 min). The pellet was washed with 
75% ethanol. After a centrifugation step, the pellet was dried and dissolved in RNAse-free 
water. Finally, the concentration and quality of the RNA was determined with the Agilent 
Bioanalyser (Agilent Technologies) and stored at -80°C.                
cDNA was synthesized by reverse transcription of 5 μg RNA with oligo dT18 using 
Superscript II reverse transcriptase (Invitrogen) according to the manufacturer’s guide. In 
brief, 1µg of total RNA was mixed with 2 µl of random primers (pdN6 50 µM, Stratagene) 
and filled up to 15 µl with nuclease free water. After incubation for 5 min at 70°C and cooling 
for 2 min on ice, 5 µl 5x reaction buffer (Promega), 1.25 µl dNTPs (10 mM, Stratagene), 1 µl 
RNase inhibitor (Rnasin 40 U/µl, Promega), 1.75 µl nuclease free water and 1 µl M-MLV-RT 
(200 U/µl) were added. The samples were incubated for 1 h at 37°C and stored at -20°C until 
use.                
Each sample for real-time RT-PCR analysis contained 200 ng of cDNA, SYBR Green Master 
Mix and 0.4 μM of each primer. The PCR amplification and real-time fluorescence detection 
were performed with the Opticon III instrument (MJ Research) using the QuantitectTM 
SYBR1 green PCR kit (Qiagen). As quantification standard defined concentrations of 
annexinA7 cDNA (Döring et al., 1991) were used for amplification. PCR amplification was 
carried out according to the manufacturer’s instruction and all PCR products were amplified 
in a linear cycle. GAPDH mRNA was employed as an internal standard, and each gene 
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expression was determined by RT-PCR and normalized against WT GAPDH mRNA levels. 
All PCR products were amplified in a linear cycle. Data are the mean +/-SD from three 
samples per group of four independent experiments. 
 
4.26 Mass spectrometry analysis 
The GFP-trap beads (Chromtek) were incubated with the lysate of the AX2 cells expressing 
GFP-CEP161 with the lysis buffer at 4
0
C for 2 hours. AX2 cell lysate incubated with the GFP 
beads served as the negative control. The beads were washed with the wash buffer for two 
times. The beads were centrifuged 1000 rpm for 2 min and the supernatant discarded. The 
beads were boiled in 2x SDS buffer (2% SDS and 1M Tris/HCl, pH 6.8) at 95
0
C for 5 min. 
The supernatant was taken for liquid chromatography-electrospray ionization-tandem mass 
spectrometry (LC-ESI-MS/MS) 2.5 h-Gradient analysis.  
 
4.27 Miscellaneous experiments 
4.27.1 D.discoideum cell size 
Cell size was determined using cells that had been treated with 20 mM EDTA in Soerensen 
phosphate buffer in order to obtain perfectly round cells. Approximately 800 cells each for 
AX2 and the mutants were measured. 
 
4.27.2 Protein sequence alignment 
Protein sequences of CDK5RAP2 proteins from H. sapiens (Q96SN8), D. melanogaster 
(P54623) and D. discoideum (Q54RX7) and protein sequences of MST1 proteins from  H. 
sapiens (Q13043), D. melanogaster (Q8T0S6) and D. discoideum Hrk-SvkA (O61122) were 
retrieved from Uniprot protein database and aligned using ClustalW program with Blosum 62 
matrix. The aligned sequences were processed through EsPript for representation. 
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5. Summary 
CEP161 is a novel component of the Dictyostelium discoideum centrosome and is the 
ortholog of mammalian CDK5RAP2. Mutations in CDK5RAP2 are associated with 
autosomal recessive primary microcephaly (MCPH), a neurodevelopmental disorder 
characterized by reduced head circumference, a reduction in the size of the cerebral cortex 
and a mild to moderate mental retardation. Here we show that the amino acids 1-763 of the 
1381 amino acids of CEP161 protein are sufficient for centrosomal targeting and centrosome 
association. AX2 cells over-expressing truncated and full length CEP161 proteins have 
defects in growth and development. Furthermore, we identified the kinase SvkA 
(severinkinase A) as its interaction partner which is the D. discoideum Hippo related kinase 
designated here as Hrk-svk. Hrk-svk is the direct homolog of human MST1. Both proteins co-
localize at the centrosome. We further demonstrate that this interaction is also conserved in 
mammals. We were able to show that CDK5RAP2 interacts with MST1 and TAZ and it also 
down-regulates the transcript levels of TAZ in HEK293T cells. Taken together, our data on 
Dictyostelium CEP161 and human CDK5RAP2 supports the hypothesis that CDK5RAP2 as a 
novel regulator of Hippo signaling pathway. We propose that CDK5RAP2 mutations may 
lead to a decrease in the number of neurons and the subsequent reduction of brain size by 
regulating the hippo signaling pathway.  
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Zusammenfassung 
CEP161, eine neue Komponente des Zentrosoms von Dictyostelium discoideum, ist das 
Ortholog des humanen CDK5RAP2. Mutationen in CDK5RAP2 verursachen MCPH 
(autosomal recessive primary microcephaly), eine Erkrankung des Nervensystems, die durch 
reduzierten Kopfumfang, eine Reduktion in der Größe der Großhirnrinde und einer leichten 
bis mittelschweren geistigen Behinderung gekennzeichnet ist. In unserer Arbeit haben wir 
gezeigt, dass die Aminosäuren 1 bis 763 der 1381 Aminosäuren von CEP161 ausreichend 
sind für das zentrosomale Targeting und für die Verbindung zum Zentrosom. AX2-Zellen, die 
verkürztes und Volllängen CEP161 über-exprimierten, hatten Wachstums- und 
Entwicklungsdefekte. Darüber hinaus haben wir die Proteinkinase SvkA (severinkinase A) als 
Interaktionspartner von CEP161 identifiziert. SvkA ist die D. discoideum Hippo-
verwandteproteinkinase, sie hier als Hrk-svk bezeichnet und ist das direkte Homolog der 
humanen MST1. Beide Proteine colokalisieren am Zentrosom und wir haben gezeigt, dass 
diese Interaktion auch beim Menschen konserviert ist. Weiterhin konnten wir zeigen, dass 
CDK5RAP2 mit MST1 und TAZ interagiert und TAZ in HEK293T-Zellen transkritionell 
abreguliert. Zusammenfassend unterstützen unsere Daten von Dictyostelium CEP161 und 
humanem CDK5RAP2 die Hypothese, dass CDK5RAP2 ein neuer  Regulator des Hippo 
Signalübertragungswegs ist. Wir schlagen vor, dass CDK5RAP2 Mutationen zu einer 
Verringerung der Anzahl der Neuronen und damit  zu einer Reduktion der Größe des Gehirns 
durch die Regulierung des Hippo Signalübertragungswegs führen.  
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